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ABSTRACT
This project focused on developing and validating analytical methods for a range of pharmaceutical 
compounds using Capillary Electrophoresis.
Analytical methods for the determination o f tromethamine, Oxytetracycline and polypyrrolidone 
contained in pharmaceutical products were developed. Approaches to method development included 
consideration of appropriate mode of capillary electrophoresis, detection technique, suitability of 
electrolyte, effect of electrolyte pH, effect of voltage, temperature and electrolyte ionic strength variation.
Validation of the methods developed for tromethamine and Oxytetracycline included conducting 
investigations into linearity, linear range and limit of detection. Repeatability, precision and accuracy 
were also examined as well as the specifity and recovery of each method developed.
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CHAPTER 1 
INTRODUCTION
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1.1 Introduction to Capillary Electrophoresis
Capillary Electrophoresis (CE), is an analytical technique, which permits rapid and efficient separation of 
charged components. Separations are based on the differences in electrophoretic mobilities o f chared 
species that take place inside small capillary tubes.
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Diagram 1.1 Schematic Diagram of CE Instrumentation
1 . 2  Principles of Separation by CE
To perform a CE separation, the capillary is filled with an electrolyte solution and sample is introduced at: 
the source vial. The capillary ends are dipped into source and destination vials containing the electrolytic: 
and a potential is applied across the capillary. The bulk electrolyte travels by electroosmotic flow (EOF)' 
and ionic species in the sample migrate with an electrophoretic mobility (EPM) determined by their 
massxharge ratio. The analyte ions eventually pass the cell window and a response from the UV detector 
is generated and passed onto an integrator. Signals generated follow Beer-Lambert Law.
A = s c l  (Eqn. LI)!
A = Absorbance (nm), e  = Molar absorptivity coefficient, c = Concentration (mg/L) and I = path cell length (cm)
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Normally the system is configured with the source vial anodic and the destination vial cathodic. As a 
potential is applied across the two electrodes, ions in the buffer travel through the capillary to the electrode 
of opposite charge. Positively charged ions migrate towards the negatively charged electrode and 
negatively charged ions migrate towards the positively charged electrode. Neutral species in the solution 
travel at the same rate as the bulk electrolyte.
1.3 Origin of Capillary Electrophoresis
Capillary Electrophoresis represents a merging of technologies derived from slab gel electrophoresis and 
high performance liquid chromatography (HPLC). The development o f capillary electrophoresis has been 
aided by the investigations of many workers over the past century1.
Table 1.1 Historical Development of CE
Year Researcher Development
1886 Lodge H1 migration of phenolphthalein jelly
1892 Smirnow Electro-fractionation of diphtheria toxin solution
1905 Hardy Globulin movement in U-tubes with electric current
1930 Tiselius Moving boundary studies of proteins in solution
1930 Coolidge Electrophoretic separation of serum proteins in tubes of glass wool
1965 Tiselius ‘Free Zone Electrophoresis’ of virus in 3 mm i.d. rotating capillary
1981 Jorgenson& Lukács Theoretical and experimental approaches to high resolution Electrophoresis in glass capillaries
1984 Terabe Micellar Electrokinetic Capillary Chromatography for separation of neutral compounds
1989 Availability of commercial CE instruments.
At present, CE is considered a complimentary separation technique to traditional separation techniques. In 
some cases it has been shown to be the superior technique2'5 however, due to sensitivity limitations the 
method may be considered more suitable for analysis of bulk chemicals than trace analysis.
1.4 Modes of Capillary Electrophoresis
Five distinct separation techniques are available with CE. These are Capillary Zone Electrophoresis (CZE), 
Micellar Electrokinetic Capillary Chromatography (MECC), Capillary Gel Electrophoresis (CGE),
3
Capillary Isoelectric Focusing (CIEF) and Capillary Isotachophoresis (CITP). The origin o f these various 
CE modes may be attributed to the fact that CE has developed from a combination of many electrophoretic 
and chromatographic techniques. In Capillary Zone Electrophoresis (CZE), separations are based on the 
difference in the electrophoretic mobilities of solutes. Velocities of ionic species are based on a 
mass:charge ratio. In Capillary Gel Electrophoresis (CGE), solutes are separated due to differences in 
electrophoretic mobility and solute size, as analytes migrate through the pores of a gel-filled capillary. The 
use of gel allows separations based on molecular-sieving as different substances migrate with different 
velocities. In MECC, the solute partitions between a micellar phase and a solution phase. An ionic 
surfactant solution is used to provide a micellar phase to allow chromatographic separation. Organic 
analytes distribute themselves between the micellar phase and the aqueous electrolyte. CIEF utilises 
differences in isoelectric points of proteins and peptides to effect separation. Migration zones are focused 
until a steady state is reached and are migrated from the capillary by a pressurised flow. CITP is performed 
by sandwiching a sample between a leading and terminating buffer in a capillary and by applying an 
electric field in a constant current mode. All buffer and solute ions migrate through the capillary and the 
detector at the same velocity. The combination of capillary electrophoresis and chromatography has lead to 
the development of a new technique called Capillary Electrochromatography, (CEC). The separating 
capillary is partially packed with a chromatographic packing which can retain solutes by normal 
distribution equilibrium upon which chromatography depends.
1.5 Comparison of Capillary Electrophoresis with other separation techniques6
Table 1.2 Comparison of CE with other Separation Techniques
Separation
Techniques
Capillary
Electrophoresis
High-Performance
LiquidChromatography Gas Chromatography
Efficiency Hundreds o f Thousands 20,000 150,000
Sample Volume N1 pL pL
Sensitivity ppm to ppb pptr pptr
Reagent
Requirements < 10 ml buffer / day
500-1000 ml 
mobile phase / day
500-1000 ml 
mobile phase / day
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CE is gaining increasing approval as an analytical technique, which may be more suitable for the analysis 
of certain compounds and can be compared with accepted established techniques as illustrated above. Cost 
of capillaries and columns depend on the application area. CE capillaries are considerably cheaper than 
other columns and cost in the region of 30-200 Euro, IC columns range from 1500-2000 Euro while GC 
and HPLC columns may cost 150-3000 Euro. The use o f organic solvents is usually incorporated in the 
analysis of samples by both GC and HPLC while CE, in cases where organic solvents are employed, 
minimal volumes are needed. With recognised advantages and disadvantages outlined above, CE can be 
appreciated as a complimentary technique to HPLC, GC and slab gel electrophoresis.
1.6 Analytes of Interest in this Study
The objective of this study was to develop capillary electrophoresis methods for compounds used in 
commercial eye-care products. In discussions with personnel working in the analytical laboratory of an 
eye-care product production plant7, a selection of compounds were identified as being difficult to analyse 
by HPLC and other analytical techniques. These included Tromethamine, Povidone, 
Soditimcarboxymethylcellulose, Polyhexamethylene Biguanide, Tris(hydroxyethyl) Tallow Ammonium 
Chloride and Polyoxyl-(40)-Sterate.
Table 1.3 Current Methods of Analysis7
Compound Current 
Analytical Method
Detection
System
Detection Limit 
Required
Difficulties
Tromethamine Ion-Ex R.I. 1.08% Interference
Povidone GPC UV 0.6% Interference
Sodiumcarboxy
methvlcellulose
GPC R.I. 0.5% Run TimelOO min, 
Interference
Polyhexamethylene
biguanide
RP-HPLC UV 1 ppm Run Time
30 min, Interference
T ris(hydroxyethyl) 
Tallow Ammonium 
Chloride
RP-HPLC UV 0.1% Run Time 30 min, 
Flow Rate 6 ml/min
Polyoxyl-(40)-Sterate GPC R.I. 0.5% Interference
After examining the structures and carrying out a literature search, it was decided to commence this study 
with the analyte tromethamine. Hence, the aim of this study was to develop and validate a method of
5
analysis for tromethamine in an eye-care product. Current analytical methods include High Performance 
Liquid Chromatography (HPLC), Reversed Phase High Performance Liquid Chromatography (RP-HPLC), 
Gel Permeation Chromatography (GPC) and Ion-Exchange Liquid Chromatography (IC). These methods 
suffer from interference and lengthy analysis times.
Initially, it was necessary to become familiar with the technique and for this purpose a range of 
experiments were carried out using established procedures. These included analysis of benzoic acid by 
direct UV detection and analysis of inorganic cations by indirect UV detection.
1.7 Applications of Capillary Electrophoresis
CZE and MECC have been used for the analysis of a wide variety of compounds. Literature available for 
method development and validation is presented for applications mainly in the pharmaceutical industry.
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Analyte M atrix Sample Preparation Separation
Technique
Electrolyte Analytical
Performance
Reference
Inorganic and 
Organic Anions
Brine Solid Phase Extraction, 
Dilution, Filtration
CZE with Indirect 
UV Detection
Sodium Chromate 
Tetrahydrate (5 
mM), pH 8.0
R2=0.9994 
lxlO"5 - 1x10° mol/L
1
Proteins Dilution, Filtration CZE-UV Tris (50 mM)- 
Phosphoric Acid, 
pH 3.0
LOD=10"2 mg/mL 2
Enantiomers Neuromuscular 
blocking drug
Dilution, Filtration CZE-UV Phosphate (0.05M), 
pH 5.0
3
Histamine Fish Tissue Extraction, Filtration CZE-UV Citrate (20mM), 
pH 2.5
R2=0.999 
LR 0.5-lOOpg/ml 
CV<3%
Rec. 94.3-109.7%
4
Toxins Shellfish Solid Phase extraction CZE-UV Acetic Acid (0.1M), 
pH 2.0
R2=0.998 
LOD 1.5pg/ml
5
Salbutamol etc. Drugs Direct Injection CZE-UV Phosphate (25mM), 
pH 2.3
R2=0.995 
LOD 0.4pg/ml 
RSD=6.6-11.2%
6
Proteins - Direct Injection CZE-UV Phosphate(50 mM)- 
PVA, pH 3.0,5.0
RSD 1.2% 7
Estrogen,
Warfarin
Steroids Direct Injection CZE Sodium Borate- 
MeoII 
(50mM), pH 10 o
8
Paracetamol Urine Solid Phase Extraction CZE-ESMS Ammonium 
Flydrogen Carbonate 
(20 mM), pH 9.0
LR 0.1-100pg/ml 
R2=0.9996
9
Denopamine Tablets Dilution, Filtration CD-CZE Phosphate(25mM)- 
Urea(2M), pH 2.5
Ri=0.999 
RSD 0.1-0.2%
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Table 
1.4 
Literature 
Review 
for 
C
ZE
Inorganic
cations/anions
Food Solid Phase Extraction CZE-Indirect UV Sodium Chromate 
Tetrahydrate 
(5 mM), pH 8.0
11
Organic Acids Food Thawing, Dilution CZE-Indirect UV Phthalate (5 mM), 
pH 5.6
RSD 1.2% 
LR 10-50pg/ml 
R2>0.999
12
Vitamin C Food Centrifugation, 
Filtration, SDS 
Addition
CZE-UV Borax (35 mM), 
pH 9.3
13
Codeine,
Morphine
Crude opium Centrifugation, 
Dilution, Filtration
CZE-UV Ammonium 
Acetate(25mM)- 
Acetic Acid(lM)
15
Proteins Serum Dilution CZE-UV Boric Acid (50mM), 
pH 9.7
£ 
—
 
ON 
^
ö 
V
II 
> 16
Sulphonamides Pork Meat Extraction CZE-UV Phosphate(0.02M)- 
Borate(0.02M), 
pH 7.0
R =0.999 
LR 2-9 pg/ml 
Rec 100% ■: s
17
Phenylalanine Drug Direct Injection CZE-UV Phosphate (0.05M), 
pH 2.0
18
Cleaning
Surfactants
Eye-care
solutions
Direct Injection CZE-UV Copper Sulphate 
(4 mM)-H2S 04(lM), 
pH 3.0
R'=0,9995 
LR 0.15-0.3 pg/ml 
RSD 1.5% 
Rec. 100%±1.5%
19
Table 
1.4 
Literature 
Review 
for C
ZE
Analyte M atrix
Sam ple
Preparation
Separation
Technique
Electrolyte Analytical Perform ance Ref
Vitamins,
Penicillins,
Antibiotics
Cold
Medicine None MECC
Phosphate -Borate (0.02M)-SDS- 
TAA Salts, pH 9.0 - 25
Antibiotics Animal Feed
Extraction,
Centrifugation MECC
Sodium Tetraborate Decahedrate 
(20 mM)-SDS (150mM), pH 9.2
R2=0.9992 
LR=0.01-0.2 pg/ml 
RSD<4%
Rec. 98.4-108%
26
Insecticides Soil,Vegetation
Extraction,
Centrifugation MECC
Borate(200mM)- 
Phenylphosphonic Acid 
(10 mM), DDAOH/ CTAOH
LOD=75pg/L 27
Proteins Meat
Extraction,
Centrifugation MECC
Borate (lOOmM)- 
SDS (75 mM), pH 8.4 LOD=l pg/ml 28
Amino, Thiol Drugs DirectInjection
Derivatisation MECC Borate (O.lM)-SDS(lOmM), pH 9.5 - 29
Dyes Flair
Addition of 
Sodium 
Sulphite
MECC Phosphate-Borate (25mM)-SDS(75mM), pH 5.5 R2=0.9812-0.9962 30
Cefotaxime DegradationProducts
Direct
Injection MECC
Phosphate (30mM)-SDS 
(I65mM), pH 7.2
R2=0.9993 
LR=0.05-1.50 g / L 
RSD<2% 
REC.98.5-98.9%
31
Table 
1.5 
Literature 
Review 
for M
EC
C
Biological
Surfactants -
Direct
Injection MECC
Phosphate (50mM)-SDS(10mM), 
pH7.0 Dehydrocholate - 32
Hydrochlorothiazide
Chlorothiazide Drug Matrix
Direct
Injection MECC
Borate (20mM)-SDS (20mM), pH 
9.5
R2=0.998 
LR=0.5-1.5 mg/ml 
RSD 1-2% 
LOD= 1 pg/ml 
Rec.=99.5%
33
Lead and Selenium 
Compounds
Environment 
al Samples
Extraction,
Drying,
Filtration
MECC
Phosphate-Borate (25mM)-SDS 
(50mM), pH 6.0
R2=0.998-0.999 
LR=0.5-1.5 mg/ml 
RSD 1-2% 
LOD= 8-20 pg/ml 
Rec.= 83-104%
34
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CHAPTER 2 
THEORY
11
2.1 Capillary Zone Electrophoresis (CZE)
Separations by CZE are performed in a homogenous carrier electrolyte. Ionic components are separated 
into discrete bands when each solute’s individual mobility is sufficiently different from all others.
D ETE C TO R
■vWINDOW
■DIRECTION OF SEPARATION
a n
Diagram 2.1 Separation of a Three Component System33
2.1.1 Order of Elution
If a sample is introduced into the capillary at the positive end, positively charged ions will travel through 
the capillary towards the negatively charged electrode at a rate faster than the neutral species. The 
negatively charged ions will be pulled back toward the positively charged electrode and will therefore 
travel toward the negatively charged electrode at a slower rate than the neutral species. Hence the order of 
elution will be (i) positively charged ions, (ii) neutral species and (iii) negatively charged ions. The order 
of elution will be reversed if the sample is introduced into the capillary at the negative end of the capillary
2.1.2 Fundamental Features Required for Separation
Four fundamental features required for good separations in capillary electrophoresis are:
(a) individual mobilities of each solute in the sample differ from one and other,
(b) background electrolyte is-homogenous and the field strength distribution is uniform throughout the 
length of the capillary,
(c) solutes nor sample matrix elements interact or bind to the capillary wall,
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(d) conductivity of the buffer substantially exceeds the total conductivity of the sample components.
2.1.3 Capillaries
Capillaries used in CZE are fused silica capillaries or capillaries packed with an internal coating. The 
selection of the capillary depends on the application.
2.1.3.1 Fused Silica Capillaries
The cost of silica capillaries depends on the instrument being used. These capillaries, precut to size, cost 
from approximately 150-200 Euro and are frequently employed in Beckman and Hewlard Packard 
instruments. Fused silica capillaries can also be purchased uncut and range from 30-40 Euro per meter. On 
column detection is facilitated by the creation of a capillary cell window. The fused silica capillary is 
transparent to UV and visible light and therefore the capillary itself can be used as the detector cell.
IIG H T
c m n N G
Diagram 2.2 Capillary Cell Window
2.1.3.2 Capillary Dimensions
Capillaries with internal diameters o f 50-100 pm, and outer diameters of 375 pm are most frequently used. 
Migration time is directly proportional to the capillary length therefore longer capillaries will induce longer 
migration times, however efficiency and resolution will be increased. As the capillary length increases, an 
associated decrease in the electrical field strength at constant voltage occurs and this enables the use of 
higher voltages. Short capillaries are useful for fast method development, conducive for the analysis of less
complex mixtures, or when selectivity or migration times are excessive1. Long or narrow capillaries are 
useful for high efficiency and resolution needs, analysis of complex matrices, or when analysis times are 
inadequate1. The main advantage resulting from increasing the capillary inner diameter is the enhancement 
of detector sensitivity, however accompanying an increase in diameter is a decrease in the surface-to- 
volume ratio. This may lead to less efficient dissipation of Joule heat which then results in a temperature 
gradient across the capillary and band broadening due to thermal effects.
2.1.4 Injection Techniques
In CZE, sample introduction may occur by hydrodynamic injection or by electrokinetic injection. 
Hydrodynamic injections may be performed by gravity or pressure. Sample introduction by gravity 
injection is the most common injection method as it offers good reproducibility35. It relies on the siphoning 
of the sample into the capillary by elevating the injection (inlet) end of the capillary relative to the outlet 
end. Hydrodynamic injection can be achieved by placing the end of the capillary into a sample solution 
followed by moving the sample container and column end to a certain height Ah, higher than the opposite 
end of the capillary for a period of time. The volume injected, q, is given by
q = p g r* Ah tt (Eqn. 2.1)
8 r| L
q = injection volume, p  = density o f  sample solution, g  = constant fo r  gravitational acceleration, r  = internal radius o f  
capillary, Ah = height difference between anodic and cathodic capillary ends, t = duration o f  injection, rj = solution viscosity 
and L = total capillary length.
The amount injected is represented as a function of the sample concentration C as
w = p g n r4 Ah C ti (Eqn. 2.2)
8 r| L
w -  the amount o f  sample injected, p  = density o f  the sample solution, r = internal radius o f  capillary, Ah = height difference 
between anodic and cathodic capillary ends, C = concentration, ti = injection time, rj = solution viscosity and L = capillary 
length.
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Thus, the amount injected is independent of the electrophoretic mobility, and the composition of the 
sample solution has no effect on the amounts injected by this method. The quantity introduced can be 
controlled by variations in the injection time, tj, and the injection height Ah.
2.1.4.1 Pressurised and Vacuum Injection
During pressurised injections, pressure is applied to the vial containing the sample, pushing it into the 
capillary. During vacuum injection, a sample is placed at the opposite end of the capillary, drawing the 
sample into the capillary. The amount of analyte injected with pressure can be calculated from the 
Poiseuille law.36
W = AP k r4 Ah C h (Eqn. 2.3)
8 r| L
where AP = pressure difference across the capillary.
Other injection techniques include electric sample splitting methods, split flow syringe systems, rotary 
injection, freeze plug injection, optical grating and microinjection techniques.
Detection methods used in CE
2.1.5 Detection
Many detection systems have been successfully coupled with CE35, these include UV / visible 
fluorescence, mass spectrometry, conductivity, amperometric, radiometric, raman-based and refractive 
index detectors. Most commercial instruments have, as standard, a UV / visible detector, some have 
fluorescence and conductivity available and can be purchased separately. The standard UV / vis detector 
allows detection of organic components which have chromophores and coloured compounds. Charged 
species which do not have a chromophore must be detected by indirect photometric detection.
2.1.5.1 Direct UV Detection
The principle of UV / vis absorbance detection is based on Beer-Lambert’s Law. Direct UV detection is 
used to detect compounds that have an intrinsic UV absorbing species. The chromophore is the light
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absorbing part of the molecule and thus according to the Beer-Lambert Law, the absorbance signal 
generated by the analyte passing through the capillary depends on ( 1 ) the chromophore of the solute, (2 ) 
wavelength of incident light and (3) pH and composition of the run buffer. Compounds may be detected at 
their UV maxima using aqueous electrolyte systems that exhibit very stable baselines at low absorbance 
values.
2.1.5.2 Indirect Photometric Detection
This is used for detecting charged species which can be separated by CE but which do not have a UV 
chromophore. It is achieved by incorporating a chromogenic reagent into the electrolyte thus giving a 
constant high background UV absorbance. The mechanism of indirect UV detection involves the physical 
displacement by the analyte of interest of some of the chromogenic molecules in the electrolyte, as a result, 
decrease in absorbance is observed.
Indirect Detection
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Diagram 2.3 Indirect UV Detection
For lower limits of detection, indirect detection requires a well characterised displacement mechanism such
as charge displacement, a large transfer ratio and a very stable background. The transfer ratio refers to the
number of chromogenic molecules displaced by an analyte molecule while charge displacement refers to
an anionic signal generation being displaced by an anionic analyte molecule. As the analyte concentration
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is decreased, smaller differences between the background signal and the chromogenic signal are observed.
chromogenic species.
2.1.6 Electroosmotic Flow and Electrophoretic Mobility
Bulk electrolyte travels through the capillary by eletroosmotic flow (EOF) and the analyte molecules are 
separated due to differences in electrophoretic mobility (EPM).
2 .1 .6 .1 Electroosmotic Flow
When using fused silica capillaries, the inner surface of the capillary acquires a charge when a high pH 
buffer is introduced. This is thought to occur due to the ionisation of the capillary. Using electrolyte at pH 
> 3 , the surface silanol (Si-OH) groups are ionised to negatively charged silanoate (Si-O ) groups. New 
capillaries conditioned with NaOH or KOH facilitate this ionisation. The silanoate groups attract positively 
charged cations that form a positively charged layer on the inner wall of the capillary. These cations are not 
of sufficient density to totally neutralise the negative charges of the silanoate, so a second layer of cations 
forms. The Si-O' groups attach a fixed layer of positive ions tightly at the capillary surface and a second 
layer of positive cations are held less tightly because they are further from the Si-O' charges.
Sensitivity and limit of detection can be optimised in indirect UV detection by careful selection of the
POWER
+ SUPPLY
0 ©
ELECTROOSMOTIC FLOW
■>
Buffer B u ffe r
ANODE-(+) CATHODE (-)
Diagram 2.4 Electroosmotic Flow
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The second layer of positive charges are mobile. As soon as an electric field is applied to the outer mobile 
layer, this layer of cations is pulled towards the negative electrode. Thus, the movement o f the bulk 
electrolyte causes electroosmotic flow as the positively charged cations are solvated.
ELECTRO O SM O TIC FLOW  PROFILE
Diagram 2.5 Electroosmotic Flow Profile in CE 
The velocity of the electroosmotic flow is given by
v EO F =  S  C  E / 4 71 n  (Eqn. 2.4)
where vEOP = electroosmotic velocity, e - dielectric constant o f  the buffer, f  = zeta potential, E  = applied electric fie ld  in volts 
/  cm and Tj = viscosity o f  the buffer.
2.1.6.2 Reversal of EOF
Normal polarity is to have the anode (+) at the inlet and the cathode (-) at the outlet. In this format, the 
EOF travels towards the cathode (detector). Order of elution follows positive ions, neutrals and negative 
ions. If the polarity is reversed, the direction of the EOF is away from the detector and the order of elution 
is reversed. Thus, depending upon the charge of the analyte, the electrode polarity is altered.
2 .1.6.3 Measurement of EOF
The electroosmotic velocity ( v e o f )  and electroosmotic mobility ( p -e o f )  can be determined by injecting an
uncharged species (neutral marker) into the capillary.
v e o f  -  L  tnm -  distance / time ( cm / s'1) (Eqn. 2.5)
H  length o f  the capillary from the inlet to the detector, im m igration time.
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P e o f  = V e o f  / E = cm2 / V . s'1 (Eqn. 2.6)
Neutral Markers chosen in any system must be (a) uncharged at the pH of the buffer, (b) detectable by the 
detector used, (c) pure, (d) unreactive with the capillary walls and (e) soluble in the buffer.
2.1.6.4 Electroosmotic Mobility
The electroosmotic mobility of the buffer, p e o f  , is given by
PEOF=eC/4 7tr| (Eqn. 2.7)
where Peof -  electroosmotic mobility, s  = dielectric constant o f  the buffer, £=  zeta potential, and rj = viscosity o f  the buffe.r 
Thus the electroosmotic mobility is dependent on buffer characteristics such as dielectric constant, 
viscosity, pH and concentration but is independent of the applied electric field.
2.1.6.5 Electrophoretic Mobility
Analytes are separated in CE on the basis of the rate at which they travel through the capillary,
electrophoretic mobility ( p e p ) .  Electrophoretic Mobility ( p e p )  of a charged molecular species can be
approximated from the Debye-Huckle theory35,
P e p  =  q   (Eqn. 2.8)
6 7T r) r
where q = charge on the particle, tj = viscosity o f  the buffer and r = Stoke's radius o f  the particle.
The mass of the particle may be related to the Stoke’s radius by
M =  (4A )n r 3 V (Eqn. 2.9)
where M  = mass o f  the particle, r = Stoke's radius o f  the particle and V = applied voltage.
Under the influence of an electric field an electrically charged solute will migrate through a buffer with an 
electrophoretic velocity, v e p ,
V e p  = P e p  E (cm / s) (Eqn. 2.10)
pEp= q / 6 p r| r (cm2 / V . s) (Eqn. 2.11)
Pep = electrophoretic mobility, E  = applied electric field, q = charge o f  ionised solute, tj = buffer viscosity and r = Stoke’s 
radius.
19
The greater the mass:charge ratio the greater the electrophoretic mobility, and hence the electrophoretic 
velocity. Small molecules with a large charge move through the system fastest, large molecules with a 
small charge move slowly through the system, Neutral species have zero charge (q = 0) therefore they do 
not have electrophoretic mobility. Electrophoretic mobility is affected by solvent viscosity in the same way 
as electroosmotic velocity.
VoBS =  V e p  +  v e o f  (Eqn. 2.12)
Mo b s  =  Me p  =  Me o f  (Eqn. 2.13)
Electrophoretic velocity and mobility for any solute can be determined by measuring the electroosmotic 
velocity and the observed velocity,
vEp = / / t m-/ / tnm (Eqn. 2.14)
tm = migration time o f  solute, t„m = migration time o f  neutral marker, I = effective length o f  capillary.
| i E P  = ( / / t m- / / t nm) ( L /  V) (Eqn. 2.15)
L = total capillary length, V = applied voltage.
Solvent viscosity, temperature, electrolyte pH and ionic strength will also affect the electroosmotic flow.
2.1.6.6 Migration Time
Migration time, tm, is the time taken for the solute to travel from the capillary inlet to the detector and 
depends on both EOF and EPM.
t m = I / Vo b s  (Eqn. 2.16)
Vo b s  =  Mo b s  E (Eqn. 2.17)
Therefore, V  = I /  Mo b s  E (Eqn. 2.18)
Also, sinceE = V / L tm = /L  / pobs V (Eqn. 2.19)
On substitution: tm = ( Me p  + Me o f  ) V (Eqn. 2.20)
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2.1.7 Background Electrolyte
The electrophoresis buffer is o f key importance because its composition fundamentally determines the 
migration behaviour of the analytes. A suitable electrolyte must ensure1 (a) the correct electrophoretic 
behaviour of all individual solutes, (b) the overall stability of the system and (c) satisfactory separation of 
the analytes. The majority of buffers used in CE are aqueous electrolytes36.
2.1.7.1 Analyte Ionisation
It is important to consider the degree of ionisation of the analytes in the solution. In the case of weak acids
or bases, their degree of ionisation depends on the pH of the solution. For a monovalent weak acid HA,
which has a dissociation constant Kn\ and the degree of dissociation is given by:
ATha = Cg+ . Ca~ (Eqn. 2.21)
Cha
where, C f  =the concentration o f  the ion A', Cjja -concentration o f  the non-ionised weak acid, CA =total concentration o f  the 
weak acid and CH+= is the concentration o f  the proton,
(Xa =  Cah+ =  Ch+ (Eqn. 2.22)
CA ATah+ + Ch+
In weak electrolytes, both the non-ionised molecules and the corresponding ions may be present. Although 
each type of particle may have its own value of mobility, they behave as a uniform substance since both 
types of particles mutually interchange by rapid reversible acid-base equilibrium. The mobility o f the 
substance is given by:
Ma =  Ma a A (Eqn. 2 .23)
where pA = mobility o f  the ion A'.
The dependence of aA on pH is similar to the dependence of ma on pH. For the protonation of a weak base, 
the dissociation constant of its protonated form, K m ,  the degree of protonation a E and the effective 
mobility of the base B, mb are given by
ATbh+ = Ch+ . Cb (Eqn. 2.24)
Cbh+
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or, PBHCIbH (Eqn. 2.25)
where CB= concentration o f  the non-ionised base, CBH+-  concentration o f  the protonated form o f  the base, CB= total 
concentration o f  the base, CH+= concentration o f  the base, C ,f  - concentration o f  the proton and pBn is the mobility o f  the ion 
B i t .
Thus mobilities of ions through the electrolyte is dependent upon their degree of ionisation within the 
system.
2.1.7.2 Electrolyte pH
Electroosmotic and electrophoretic mobilities are effected by changes in buffer pH.
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Diagram 2.6 Effect of Electrolyte pH
As the pH increases, the charge on the inner capillary wall increases (as more Si-OH groups dissociate to 
Si-O') therefore the electroosmotic flow increases. The zeta potential is proportional to the charge on the 
internal capillary wall and the buffer potential affects the electroosmotic flow. Electrophoretic mobility is 
also altered as a consequence of buffer pH as the degree of ionisation of solute depends on the pH of the 
solution. Differences in the degree of ionisation give rise to differences in electrophoretic and
22
electroosmotic mobilities. Consequently, both the separation efficiency and flow velocities may be affected 
by the buffer pH. By pH adjustment, both electroosmotic and electrophoretic mobilities can be altered.
At low pH values there is less ionisation of the silanol groups and therefore the zeta potential is low and 
the electroosmotic flow is low. At pH values below 2 there is no electroosmotic flow in fused silica 
capillaries as all the silanol groups are protonated. Ionisation of the silanol groups on the inside of the 
capillary start at values greater than pH 2. Between pH 2 and pH 5, the ionisation of the silanol groups is in 
a dynamic equilibrium. At higher pH values the EOF begins to slow down.
The pH of the buffer also effects the degree of ionisation of the buffer and analytes and hence the 
electrophoretic mobilities of the analytes. The electrophoretic mobility and charge of anions in the 
electrolyte is dependent on the pH of the buffer. Anionic mobility increases as the pH increases as the 
anionic analyte pass through the capillary unhindered and reduces when the pH is lowered. In the case of 
electrophoretic mobility for cationic species, their mobility decreases as the pH is increased.
2.1.8 Joule Heat
Joule heat arises when electric current is passed through the buffer inside capillaries. High voltages result 
in increased current, which in turn leads to an increase in heat production. If this heat produced is not 
quickly dissipated, the temperature inside the capillary will rise, causing the viscosity of the buffer to 
decrease, permitting even more current to flow.
2.1.8.1 Effects of Joule Heat
Joule heat generation effects the quality of the CE separation in the following way:
(a) Temperature gradients may be generated and if they are steep enough, density gradients in the buffer 
can be induced. This in turn can cause convection currents in the capillary. Any such convection would 
serve to remix separated sample zones and therefore reduce separation performance.
(b) If temperature gradients are not large enough to cause convection, separation performance can be
compromised by introducing a spatial dependence (8) on electrophoretic mobility. This spatial dependence
of mobility can cause a deformation in the migrating zones.
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(c) If temperature of the electrolyte becomes too high, the structural integrity o f the analyte may be 
compromised.
(d) The buffer may begin to boil causing air bubbles and therefore causing the instrument to cut out.
Efficient removal of Joule heat allows CE to use high electric fields, to perform separations and achieve 
very low band dispersion. High operating voltages therefore favour the generation of Joule heat.
2.1.9 Ionic Strength
Typical buffer concentrations are chosen within the range 10-100 mM1 and as a general rule the electrolyte 
concentration should be 100 times that of the sample, Changes in ionic strength of the buffer will effect 
electroosmotic and electrophoretic mobilities from equations (2.12) and (2.13) where peof and Pep are 
directly related to rj, buffer viscosity, In general, when capillary temperatures are controlled, 
electroosmotic flow decreases in a logarithmic manner as the zeta potential is reduced with increasing ionic 
strength. Where capillary temperature is not controlled, increasing the ionic strength of the buffer may 
cause an increase in the electroosmotic flow. This in turn increases the current, and therefore, increases the 
temperature and reduces the viscosity of the buffer. Capillary cooling will allow the use of higher 
concentration buffers as at lower temperatures there will be less current produced. Effects of increasing 
ionic strength are (a) migration times increase, (b) number of theoretical plates increase, (c) better 
resolution and (d) improved peak shape.
2.1.10 Temperature
Increasing temperature decreases buffer viscosity, increases conductivity and hence increases 
electroosmotic flow35. However, increasing the temperature decreases the dielectric constant which 
decreases the electroosmotic flow. Separations should initially be attempted at close to ambient 
temperature in order to establish whether the need for temperature control arises. Variations in temperature 
can lead to a decrease in analysis time, thermal denaturation of the sample, alteration of buffer viscosity, 
electrophoretic mobility and injection volume.
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. 11 Organic Solvent Addition 
Addition of organic solvents to the buffer permits the analysis of some analytes which are not normally 
aqueous soluble by improving their solubility in the buffer. Organic solvents, e.g. Methanol, Acetonitrile 
and Tetrahydrofuran23 are also known to reduce the EOF, which may result in better resolution at the 
expense of longer analysis time. Organic solvent addition can affect the electroosmotic flow depending on 
the type and quantity of solvent used. System effects include viscosity, dielectric constant and zeta 
potential.
2.1.12 Organic Modifiers
Chemical additives may be covalently attached to the capillary wall or dissolved in the buffer to reduce the 
electroosmotic flow1. This is caused by the reduction of the zeta potential as the charges on the capillary 
wall are masked. Covalently bonded wall coatings can be used to eliminate electroosmotic flow and reduce 
sample adsorption onto the capillary wall while dynamic coatings such as surfactants and hydrophilic 
polymers26'28 are added to the buffer and adsorb onto the walls o f the capillaries, thus blocking the charges 
on the capillary wall.
2.1.13 Voltage
Optimum voltage is the maximum voltage at which insignificant Joule heating occurs. The voltage used
should be chosen to give maximum efficiency without generating excessive heat that cannot be dissipated
easily. This optimum voltage can be chosen from a graphical representation of voltage v current.
Optimum voltage is dependent on the capillary length and internal diameter. If the voltage is kept constant
and the capillary length is reduced, the resistance will decrease and hence current will increase and more
heat will be generated. The internal diameter o f the capillary will also affect the maximum voltage. Smaller
internal diameters will have higher resistances6 and therefore lower currents than larger internal diameters.
High operating voltages, short capillaries and high electroosmotic flow give shorter migration times. High
electroosmotic flow can lead to poor resolution, therefore, to reduce migration times one should
preferentially increase the applied voltage or shorten the capillary6. Both of these measures require heat
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dissipation. Analyte mobility through the capillary can be enhanced by the application of high operating 
voltages. Increased electrical application facilitates electrophoretic and electroosmotic mobility as the 
current in the capillary is altered. Lower operating voltages induce diminished migration o f the analyte. An 
optimum voltage chosen should consider the efficiency and resolution of analyte separations in a
convenient analysis time.
2.1.14 Efficiency, Selectivity and Resolution
Efficiency can be determined by measuring migration time, tm, and peak width at the base of the peak, w, 
or at half the peak height.
N = 1 6 ( t m/ w ) 2 (Eqn. 2.26)
N = 5.54 ( tm/ wi /2 )2 (Eqn. 2.27)
where = N, is the number o f  theoretical p la tes,, tm, = migration time a n d , w = peak width at the base o f  the peak.
Narrow peaks with long migration times have highest efficiencies. The bulk electrolyte travels under the 
influence of EOF and thus solute plugs do not undergo significant spreading. Zone spreading can be 
represented by spatial variance,
52 = 2 D t (Eqn. 2.28)
where, 52 ‘spatial variance, t = time andD  = solute's diffusion coefficient ( cm2 / s )  
if t = tm then,
tm = / L / ( (Xep + P eof ) V (Eqn. 2.29)
and the number of theoretical plates can be expressed as
N = L2 / 82 (Eqn. 2.30)
Then, N = ( Pep + Peof ) V / 2 D (Eqn. 2.31)
High efficiencies are obtained by increasing electroosmotic flow (provided the electroosmotic and 
electrophoretic flow are in the same direction) or increasing applied voltage.
Selectivity is the distance between adjacent peaks as they pass through the detector and is represented by 
the equation
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a  = ( t 2 - t ra„ ) / ( t i - t n m )  (Eqn. 2.32)
where t2 and t, are the migration times o f  two adjacent peaks and t„m is the migration o f  the neutral marker.
a  = v l / v2 . constant (Eqn. 2.33)
and a  = p i / p2 . constant (Eqn. 2.34)
Thus, selectivity is dependent on differences in electrophoretic mobilites o f solutes and can be altered by 
changing pH.
Resolution can be related to the operating voltage, electroosmotic flow, electrophoretic mobility and 
capillary length by the following equations:
It can initially be expressed in terms of peak efficiency and velocities o f solutes as:
R = 1/4 (N)1/2 (Av / vave) (Eqn. 2.35)
where, R= resolution, N= plate number, A v /  vm, -  relative velocity difference (A vis the velocity difference between two solutes
and vave is the average velocity o f  the two solutes)
The relative velocity difference between two solutes is related to the average electrophoretic mobilities of 
the solutes
Av / Vave = (P2 - Pi) / ( P a v e  + P e o f )  (Eqn. 2.36)
where, Peof= electroosmotic mobilityr pAvn =average electrophoretic mobilities o f  the solutes.
Upon substitution of N = ( Pep + Peof ) V / 2 D into R = 1/4 (N)1/2 (Av / vaVe ) (Eqn. 2.33),(Eqn. 2.37)
R = 1/4 [ ( p e p  + P e o f )  V / 2 D]1/2 [(p2 - pi) / ( P a v e  + P e o f ) ]  (Eqn. 2.38)
or R = 0.177 (p2 - pi) [ V / ( P a v e  + P e o f )  D]1/2 (Eqn. 2.39)
Resolution is proportional to the square root o f the voltage and high electroosmotic flow in the same 
direction as the electrophoretic mobility will decrease resolution36. Resolution will be good when there is a 
large difference in electrophoretic mobilities o f solutes that can be enhanced by optimising the pH of the 
buffer. As resolution is proportional to (/ / L)l/2 the capillary length chosen should optimise analysis time 
and effect the best resolution.
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Using high operating voltages may increase the sharpness o f the detector response and improve resolution. 
If the sample matrix ionic strength is much greater than the running buffer ionic strength, resolution and 
efficiency will suffer from changes in band broadening. In general, high voltages will increase efficiency 
while low voltages will decrease resolution and the number o f theoretical plates of the system36.
2.2 Micellar Electrokinetic Capillary Chromatography (MECC).
2.2.1 Principles of Separation in MECC.
In MECC two phases exist: an aqueous phase and a micellar phase. Solutes partition between phases 
resulting in retention based on differential solubilisation in the micelles. MECC is used to separate anions, 
cations and electrically neutral compounds. Separation is achieved by adding detergents to the run buffer. 
Detergents or surfactants have hydrophobic and hydrophilic ends and are anionic, cationic, zwitterionic or 
non-ionic. Micelles are aggregations of individual surfactant molecules that form when a surfactant is 
present above its critical micelle concentration (CMC). These micelles are spherical in shape and form 
such that the hydrophilic groups are on the outside toward the aqueous buffer and the hydrophobic carbon 
molecules are in the center. The size of micelles are in the range 3 to 6 nm in diameter and exhibit 
properties of homogenous solutions. MECC is most commonly performed with anionic surfactants 
especially sodium dodecyl sulphate (SDS)32'34, [CH -(CH2)n-0-S0], SDS has a CMC of 8.27 mM and an 
aggregation number o f 6235. The surface of SDS micelles have a large net positive charge and therefore 
exhibit large electrophoretic mobility (pep) toward the anode, which is in opposite direction to the EOF 
towards the cathode.
The magnitude of EOF is slightly greater than that of Hep, resulting in a fast-moving aqueous phase and a 
slow-moving micellar phase. Consequently, the MECC technique provides a means of obtaining selective 
separations of neutral and organic compounds while retaining the advantages of the capillary 
electrophoresis format.
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Diagram 2.7 (a) SDS micelle (b) SDS inside capillary
2.2.2 Migration of Analytes
Migration of analytes is generally governed by hydrophobicity. Micellar solutions may solubilise 
hydrophobic compounds that might otherwise be insoluble in water. More hydrophobic solutes interact 
more strongly with the micellar phase and thus migrate slower than hydrophilic compounds. The migration 
time (tm) of a solute that interacts with the micelles will fall in a ‘migration time window’ between the 
migration time (t0) of a solute that has little or no interaction with the micelles and the migration time of a 
solute that is 1 0 0 % solubilised by the micelles (tmc).
Micelle Solute W ater
I tel H I I
inj. colum n det.
W ater Solute M icelle
I ; 1--------- 1--------------------------------------- 1----->  Time
0 to tp tmc
Diagram 2.8 Migration Time Window in MECC
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The fact that neutral solutes must elute between to and tmc is the most significant difference between MECC 
and conventional chromatography. The order of elution in MECC is illustrated by a migration time 
window where water travels at a faster rate than the solute and the solute in turn travels at a faster rate than 
the micelle along the capillary.
2.2.3 Electroosmotic Flow in MECC
EOF transports the bulk solution to the negative electrode due to the negative charge on the surface of 
fiised silica. EOF is usually stronger than the electrophoretic migration of the micelle under neutral or 
alkaline conditions and therefore the anionic micelle also travels toward the negative electrode at a retarded 
velocity. When a neutral analyte is injected into the micellar solution, a fraction of it is incorporated into 
the micelle and it migrates at the velocity of the micelle. The remaining fraction of the analyte remains free 
from the micelle and migrates at the electroosmotic velocity. The migration velocity o f the analyte thus 
depends on the distribution coefficient between the micellar and non-micellar or aqueous phase. The 
greater the percentage of analyte distributed in the micelle, the slower it migrates. The analyte must 
migrate at a velocity between the electroosmotic velocity and the velocity of the micelle, provided the 
analyte is electrically neutral. To illustrate this, a capacity factor k’ is defined as:
k’ = Nmc (Eqn. 2.40)
Naq
where Nmc and Naq are the amount o f  the analyte incorporated into the micelle and that in the aqueous phase, respectively.
A relationship can be derived between the capacity factor and the migration times i.e.
k’ = t; - tn (Eqn. 2.41)
to ( 1 "tr / tmc
The migration time of the analyte is equal to t0 when k’ = 0, or when the analyte does not interact with the 
micelle at all; the migration time becomes W  when k’ is infinity or the analyte is totally incorporated into 
the micelle. Thus, the migration time window is limited to between t0 and W . When t0 is infinity (when 
electroosmosis is completely surpressed) equation (2) becomes:
tr = [l + l / k ’jtme (Eqn. 2.42)
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In this case, the bulk solution remains stationary in the capillary and the micelle migrates only by 
electrophoresis. If the capacity factor, k’, is defined as the reciprocal of equation (1), equation (3) becomes 
identical with the relationship between tr, to and k’ in conventional chromatography. Equation (2) can be 
related to electrophoretic processes. In CZE, the migration velocity o f the analyte v6 is expressed as:
vs = [ |Xeof+ Pep (s) ] E (Eqn. 2.43)
This equation can be applied in MECC by defining the electrophoretic mobilities, for the neutral analytes 
as
Pep(s) _kl Pep (me) (Eqn. 2.44)
1 + k’
where, ¡IeP (me ) = electrophoretic mobility o f  the micelle and k ' / 1  + k  ’=fraction o f  the analyte incorporated into the micelle, 
as shown by the following equation:
kl = wm (Eqn. 2.45)
1 + k’ naq + nmc
Thus the velocity of the analyte in MECC is given as
v8 = [ Peof + Pep ( s )  ] E (Eqn. 2.46)
therefore the effective mobility indicates that a neutral analyte has mobility.
2.2.3 .1 Reversal of EOF
The direction and rate of electroosmotic flow depends on the polarity and magnitude of the zeta potential. 
The direction of the EOF is normally towards the cathode in aqueous solutions. By introducing cationic 
surfactants in the MECC buffer6, the direction of the EOF can be reversed due to adsorption of the cationic 
species on the capillary wall and subsequent reversal of the zeta potential.
2.2.4 Resolution in MECC
Resolution in MECC is given by the equation:
Rs = Vn (a-1 / a )  ( k f  /  1 + k f  ) 1 - XJ tmc (Eqn. 2.47)
1 +( to/ tmc)ki ’
where, N= theoretical plate number, a  -  separation factor and k, ’ and k2 '= capacity factors o f  analytes 1 and 2, respectively.
2.2.5 Efficiency in MECC
The higher the applied voltage, the higher the plate number, unless the conditions are such that the applied 
voltage generates too much Joule heating. Average plate numbers for most analytes are usually in the 
range 100,000 to 200,0006. If the plate number is considerably lower, analytes are likely to be absorbed on 
the capillary wall. In such cases, experimental conditions must be optimised to produce more efficient 
separations. Cleaning of the capillary is a possible procedure as is changing the pH of the run buffer. 
Hydrophobic analytes, or those having longer migration times, typically yield high theoretical plate 
numbers because the micelle has a smaller diffusion coefficient. The plate number does not depend 
significantly on the capillary length. With short capillaries, however, the amount o f sample volume 
injected must be minimised to avoid zone broadening.
2.2.6 Selectivity in MECC
Selectivity is the most important and effective term to maximise resolution. Selectivity reveals the relative 
difference of the distribution coefficient between two analytes and can be manipulated by chemical means. 
Since the distribution coefficient is a characteristic of a given separation system consisting of a micellar 
and aqueous phase, the selectivity can be manipulated by changing either the type of micellar phase or by 
modifying the aqueous phase.
2.2.6.1 Capacity Factor
From the resolution equation, the optimum value of the capacity factor is equal to (tmc / t0)1/2. Under 
conditions of pH > 6, the optimum k’ value is close to 2 for most long alkyl chain surfactants31. In most 
instances, the capacity must be adjusted to between 0,5 and 10. A large capacity factor means that the 
major fraction of the analyte is incorporated into the micellar and the aqueous phase in other words an 
equal distribution between two phases.
The capacity factor is related to the distribution coefficient, K, by
k’ = K Vmc / Vaq (Eqn. 2.48)
where Vmc /  Vaq = ratio ofmicelle and aqueous volumes and V^. and Vaq - volumes o f  micelle and the remaining aqueous phase.
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The capacity factor is approximately related to the surfactant concentration Csf, by
k’ = K v ( C s f  - CMC) (Eqn. 2.49)
where, v  = partial specific volume o f  the micelle.
This indicates that the capacity factor increases linearly with an increase of surfactant concentration. 
Adjusting the surfactant concentration provided the CMC is known can therefore vary the capacity factor.
2.2.7 Electroosmotic Velocity
The effect of EOF on resolution is related to the migration time ratio, to / tmci
to / W  = [ 1 + Pep (me) / Peof ] E (Eqn. 2.50)
where, t<, /  W  = migration time window, pBP (me) = electrophoretic mobility of analyte, Peof = electrophoretic mobility o f  EOF  
and E  = applied electric field.
The mobility of peof and Pep (me) usually have different signs and the ratio Pep (me) / Peof is smaller than 
0 and larger than -1. Therefore, t0 / tmc is less than one. The t0 / W  is also directly related to the width of the 
migration time window. The smaller the value of t0 / W , the wider the migration time window, hence the 
higher resolution. In order to reduce the value of to / tmc, it is necessary to reduce Peof relative to Pep (me) 
because in practice, increasing pEp(mc) is rarely possible36. It is also possible to reduce veof by changing 
the pH of the buffer to acidic conditions.
2.2.8 Surfactants used in MECC
Mobility of micelles and binding constants of solutes are influenced by the nature of the 
hydrophobic moiety, charged head group, and counterion of surfactant-forming micelles. The 
applicability of a surfactant system in MECC depends on its solubility and CMC value.
Table 2.2 Surfactants Used in MECC36
Surfactant CMC, mM Aggregation Number
Anionic
Cholic Acid, sodium salt 14 2-4
Deoxycholic acid, sodium salt 5 4-10
Glycocholic acid, sodium salt 13 2
Sodium Dodecyl Sulphate (SDS) 8.27 62
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Taurocholic acid, sodium salt 10-15 4
Cationic
Cetyltrimethylammonium chloride 1 -
Cetyltrimethylammonium bromide 1.3 78
Dodecyltrimethylammonium bromide 14 50
Hexadecyltrimethylammonium bromide 0.026 169
Zwitterionic
CHAPS* 8 10
CHAPSOb 8 11
Nonionic
n-Decyl-p-D-glucopyranoside 2.2 -
Triton-X-100 0.24 140
a three-[(three-cholamidopropyl)dimethylammonio] -1 -propanesulfonate 
b three-[(three-cholamidopropyl)dimethylammonio]-2-hydroxy-1 -propanesulfonate
Surfactants which have very large CMC values are unsuitable because of the high conductivity produced 
which may lead to undesirable thermal effects. Together with anionic, cationic, non-ionic and zwitterionic 
micelle systems, the use of mixed micelles and reversed micelles, and the addition of modifiers36 further 
enlarges the scope and variety of the micellar phase available in MECC. With different systems, 
interactions that can occur between micelles and solutes vary and therefore selectivity changes are due to 
differences in solubilisation behaviour.
2.2.9 Organic Modifiers
Some of the most commonly used additives to enhance efficiency and selectivity in MECC are 
hydroxypropylcellulose (HPC), hydroxyproplymethylcellulose (HPMC), Brij-35 and Tween-2026,28'29. The 
addition of methanol10,14,16'18 is also known to decrease the electroosmotic velocity while that of urea34 
addition has been demonstrated to effect the formation of micelles with a resultant decrease in capacity 
factor for most solutes. The presence of organic solvents into a micellar solution causes a reduction in EOF 
and hence an extension of the elution time window and a decrease of the migration factor, k’.
2.3 Comparing CZE and MECC
MECC differs from CZE in that it uses an ionic micellar solution instead of a buffer salt. The micellar 
solution generally has a higher conductivity and hence causes a higher current than the buffer does in CZE. 
MECC can separate both ionic and neutral substances while CZE typically separates only ionic substances.
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Thus MECC has a great advantage over CZE for the separation of mixtures containing both ionic and 
neutral compounds. In MECC, the size of sample molecules are limited to values of less than 5,000 a.m.u., 
whereas CZE virtually has no limitation in molecular size. The separation principle of MECC is based on 
the distribution of the solute between the micelle and water as CZE is based on the differential 
electrophoretic mobility.
2.4 Ion Chromatography
2.4.1 . Principle Components of an 1C System
The key components of an IC system comprise a high pressure pump, separator column, suppressor 
column and a recording conductivity instrument.
Diagram 2.10 Principle Components of an IC System
sample eluant
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2.4.2 Ion Exchange Column
The ion exchange column contains a packing of pellicular resin which owing to their small particle size 
(10-25 pm) present a high surface area and short diffusion paths therefore promoting very fast rates of 
exchange and rapid resolution of mixed ions. The resins used are of low capacity (0.005-0.02 meq g'1) 
which for cation analysis are surfaced sulfonated copolymer microspheres. An anion exchange resin is 
obtained by surface coating a pellicular cation exchanger with a quaternary ammonium latex (0.1-1.0 pm 
particles) co-ploymer which becomes irreversibly electrostatically bonded to the host particle. Because of 
the deliberate low column exchange capacity the elution times for total ion loadings of only a few mg are 
very short. The eluting agents are prescribed according to the known or anticipated ions present and are 
pumped at a controlled rate down the column.
2.4.3 Mechanism of Cation Analysis
The suppressor column contains a finely graded anion exchange resin which interacts with cations in the 
sample according to charge. Prior to elution, the suppressor column only sees the eluent (HY) and the 
following exchange takes place:
ROH + HY=> RY + H20  (Eqn.4.1)
The conductivity of the column effluent is that of water and therefore has been suppressed. During the 
elution of each cation the suppressor column only sees electrolytes BY and HY. The conductivity detector 
due to HY is nullified but BY exchanges to give highly conductive hydroxide ions:
ROH + BY => RY + B+ + OH' (Eqn. 4.2)
When elution of the first cation is complete, only the eluent is present and the conductivity falls again to 
that of water. The conductivity increases again as each of the other cations in the sample travel down the 
column. Each cation interacts with the ion exchange material in the column so that their retention time is 
proportional to their size and charge. Ion detection is determined through a series of peaks detected by the 
conductivity detector whose retention time and size is characteristic of the ion present and its 
concentration, respectively.
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2.4.4 Order Of Elution.
The order of elution follows that the greater the size and charge of the cation, the slower it will travel 
through the column. In a mixture of four cations, M4', M3+, M2+ and M+, the cation with the smallest 
charge will elute more quickly than all others as it is retarded the least. The partition coefficient is related 
to the ions interaction between the stationary phase and the mobile phase. The more strongly a solute 
favours the stationary phase, the lower the retardation,
Order of elution follows:
m 4+ > m 3+ > m 2+ > m "
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CHAPTER THREE 
BENZOIC ACID
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3.1 Introduction
In order to become familiar with the CES 1 instrument, a previously reported analytical procedure47 for the 
determination o f Benzoic Acid was carried out.
Structure of Benzoic Acid
COOH
Diagram 3.1 Structure of Benzoic Acid
Benzoic acid contains a carboxylic acid group attached to an aromatic ring and absorbs UV light at 215 
nm. Direct UV detection was used to analyse a 10-50 mg / L sample using a borate buffer at pH 7.
3.2 Literature Review
Benzoic acid has been analysed by GC37'39, IC40, HPLC41'45 and CE.46-49 Benzoic acid is routinely added to 
food where it functions as a preservative, anti-oxidant and sweetner.
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Table 3.1 Benzoic Acid Literature Review
Matrix
Separation
Technique
Analysis
Time
Linear
Range R2 LOD
Precision
and
Accuracy
Recovery Ref
Food
GC 7 mir 0.4-25mg/L 0.999
0.15
mg/L RSD=3.0% 103% 37
Oils and 
Cheese
GC 5 min 1.5-500Mg/ml -
0.8
pg/ml
RSD=3.5% 92.8-102.5% 38
Urine GC 5 min - - - - - 39
Sweetners IC 6 min
1-40 pg
/ml 0.9997
10
ng/ml RSD=1.0% 85-104% 40
Wine RP-HPLC <10 min
0.005-
100
ng.ml
0.999 10
pg/ml
RSD=0.6% - 41
Fruit Juice HPLC 27 min - - - - - 42
Syrup HPLC 15 min 0.1-0.3 mg/ml 0.9995 - RSD=1.38% 100% 43
Drugs RP-HPLC 7 min 0.25-50pg/ml 0.9996
0.5
pg/ml
RSD=3.0% 85-95% 44
Cosmetics HPLC 7 min
1-20
pg/ml >0.999 4 ng/ml
RSD=2.6% 99% 45
Drugs CZE 15 min
0.006-
0.113
mg/ml
0.9998
2.6
M-g/ml
RSD=0.53-
1.46% 95.1% 46
Soft
Drinks CZE 2 min
1-400
pg/ml 0.9958
4
pg/ml
RSD=0.37-
2.4% 100.6% 47
Sweetners MECC 7 min 1-50
pg/ml
0.9995 1.5
pg/ml
RSD<3.3% 98.6% 48
Drugs MECC 8 min - 0.995
A n
3
pg/ml
RSD<2.0% 100.89% 49
3.3 Method Application
3.3.1 Materials and Operating Conditions
Electrolyte: 10 mM Disodiumtetraborate, 50 mM Boric Acid, pH 7
Sample: 10-50 mg / L Benzoic Acid
Operating Conditions: Capillary Dimensions 75 pm (i.d.) x 67 cm (1) x 375 pm (o.d.)
Detection System Direct UV, at 215nm 
Polarity (+), Detector side Cathodic
Control Mode Constant Voltage, 20 kV
Injection Gravity, 50 mm for 10 sec
Temperature Ambient
(i) Electrolyte Preparation
Buffer was prepared by accurately weighing 5.283g of solid Disodiumtetraborate and dissolving in ultra 
pure water. The solution was transferred to a 1 L volumetric flask and made up to the mark with ultra pure 
water. Electrolyte pH was adjusted using 50 mM Boric acid, placed in an Ultrasonic bath for 10 min to 
degas and filtered through a Gelman Acrodisc (0.45pM) filter paper. Electrolyte was prepared fresh daily. 
(All future electrolyte preparations carried out in this work were prepared fresh daily, degassed and filtered 
as above, unless otherwise stated. All stock standard and working standard solutions were also prepared 
fresh daily, unless otherwise stated.)
(ii) Standard Preparation
A 100 mg / L stock solution of benzoic acid was prepared by accurately weighing 100 mg of the 
compound, dissolving in ultrapure water and diluting to 1 L in a volumetric flask.
(iii) Working Standard Solutions:
10, 20, 30, 40 and 50 ml of the stock solution were pipetted into 100 ml volumetric flasks and made up to 
the mark with ultrapure water. Standard solutions were prepared fresh daily.
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(iv) Capillary Preparation
The capillary was prepared by measuring accurately 50 cm in length and cutting using a ceramic scoring 
tool supplied by Dionex. A flat even capillary end was ensured. Creation of a capillary cell window at a 
distance of 4.5 cm from one end was achieved by burning the polyimide coating using a lighter. Remnants 
of the polyimide coating were removed by gentle cleaning of the cell window with lens tissue soaked in 
methanol. The capillary was installed into the instrument, conditioned by washing with 1 M NaOH for 30 
min, followed by ultrapure water for 30 min and equilibrated with the run buffer for 30 min. The capillary 
was rinsed with electrolyte for 1 2 0  sec between injections to remove any residue from previous analysis 
and to maintain reproducibility from injection to injection. Performing injections of water and electrolyte 
ensured baseline stability. Each standard was injected three times.
3.3.2 Results:
A response appeared at approximately 5 min.
Diagram 3.2 (a) Electropherogram of 50 mg/L Benzoic Acid in ultra pure water.
Conditions; 10 mM Disodium Tetraborate -  50 mM Boric Acid Buffer (pH 7); UV detection at 215 nm;
Capillary: 50 cm x 50 |um i.d.;Voltage, 20 kV; Gravity Injection, 50 mm for 10 s.
Peak height values were more appropriate than peak area values for constructing a calibration graph as the 
variation in readings was less obvious. Concentrations of benzoic acid were plotted against peak height to 
examine the correlation coefficient obtained.
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Diagram 3.2 (b) Electropherogram of 10, 20, 30, 40 and 50 mg/L Benzoic Acid in ultra pure water. 
Conditions: 10 mM Disodium Tetraborate ~ 50 mM Boric Acid Buffer (pH 7); UV detection at 215 nm;
Capillary: 50 cm x 50 (am i.d.;Voltage, 20 kV; Gravity Injection, 50 mm for 10 s.
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CHAPTER FOUR 
INORGANIC CATION ANALYSIS
44
4.1 Introduction
The first compound chosen for determination by CE was tromethamine. Since this compound has no 
intrinsic UV absorbing properties, it was decided to use previously reported methods50 ,51 ,52 using indirect 
photometric detection for analysing inorganic cations Li+, Na+, K+, Mg2+, Ca2+ and N H /. Tromethamine 
contains an amino group that forms an ammonium ion at pH 4.8. This method was chosen to examine 
suitability of operating conditions for the migration of tromethamine as a cation,
4.2 Literature Review
Inorganic cations are smaller and thus have higher charge densities than most organic ions therefore their 
electrophoretic mobilities are higher. The problems connected with CE analysis of inorganic cations are 
due to small differences in their migration rates and their low absorption of UV radiation. Complexation of 
the cation is used to change the selectivity and / or to facilitate the detection. Many of these references 
contain indirect UV detection, those which do not involve off-line preparation of complexes prior to CE 
analysis.
Table 4.1 Literature Review for Inorganic Cations
M atrix SeparationTechnique Detector
Analysis Time 
(min)
Analytical
Performance Ref
Drinking Water CZE Indirect UV Detection < 6 min (Method Only) 52
Drinking Water CZE
Indirect UV 
Detection < 4.5 min (Method Only) 53
Metal Salts CZE Indirect UV Detection < 6 min
L.R.=50-150
(ig/ml
R=0.9996 
RSD=1.26% 
LOD=33 jag/ml
54
Metal Salts CZE
Indirect
Eluorometric
Detection
< 5min (Method Only) 55
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Table 4.1 Literature Review for Inorganic Cations
Pharmaceutical
Matrix CZE
Indirect UV 
Detection
< 4.5 min
L.R.=5-50 gg/ml 
R=0.9999 
RSD<0.35% 
LOD=0.5ftg/ml
56
Cation
Standards IC
UV Detection < 6 min
L.R.=0.5-5 
m g/ L 
LOD=0.5mg/L 57
Brine IC UV Detection < 8 min (Method Only) 58
Aerosols CZE UV Detection < 6 min RSD=0.5% 59
Metal Salts CZE indirect UV Detection < 7 min
(Method Only) 60
Beverages CZE Indirect UV Detection < 8 min
R=0.9987 
L.R.=10- 
100,ug/ml 
RSD=0.6%
61
Silicone
Products
CZE Indirect UV Detection <3.5 min
R=0.9999
15-100|ig/ml
RSD<5%
62
Vegetables CZE UV Detection < 5 min LR=l-5 mg / L 63
Juice CZE
Indirect UV 
Detection < 6 min
LR= 
4 x 1 0 '5-2 x 10"2 M 64
Soft Drink CZE
Indirect
Fluorometric
Detection
< 5 min
LR=
1x 1 0 '7-3 x 1 0 '6M 65
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Table 4.1 Literature Review for Inorganic Cations
Milk CZE
Indirect UV 
Detection < 4 min
Method Only 66
Tears CZE
Indirect UV 
Detection
< 6 min Method Only 67
Seawater CZE
Indirect UV 
Detection < 5 min LOD 4x1 O'4 M 68
Trace
Explosives
CZE Indirect UV 
Detection
< 9 min LOD=2xlOÌVI 69
Vitreous
Humour
CZE Indirect UV 
Detction
< 7 min Method Only 70
4.3 CE Method Application
4.3.1 Materials and Operating Conditions
Electrolyte:(a) 4 mM Copper (II) Sulphate, 4 mM Formic Acid, 4 mM 18-Crown-6-Ether, pH 5
(b) 50 mM Phosphate, 5 mM 18-Crown-6-Ether, pH 7 with 1 MNaOH
(c) 5 mM DDP, 5mM 18-Crown-6-Ether, 6 mM a-hydroxyisobutyric acid, pH 4.6 
Sample: 1-20 mg / L Li+, Na+, K+, Mg2+, Ca2+, and NH»*
Operating Conditions: Capillary Dimensions 50 pm (i d.) x 50 cm (1) x 375 pm (o.d.)
Detection System Indirect UV, at 215 nm 
Polarity (+), Detector side cathodic
Control Mode Constant Voltage, 20 kV
Injection Gravity, 100 mm for 30 sec
Temperature Ambient
(i) Electrolyte Preparation
(a) 0.4993g of Copper (II) Sulphate Pentahydrate and 0.52864g of 18-Crown-6-Ether were accurately 
weighed and dissolved in ultrapure water. The solution was transferred to a 500 mL volumetric flask and 
made up to the mark with ultrapure water. Electrolyte pH was adjusted to 5 using 4 mM Formic Acid.
(b) 7.056g Disodium Hydrogen Phosphate and 1.2216g 18-Crown-6-Ether were accurately weighed and 
dissolved in ultrapure water. The solution was transferred to a 1 L volumetric flask and made up to the 
mark with ultrapure water. Electrolyte pH was adjusted to 7 using 1 M NaOH.
(c) DDP Buffer was purchased in concentrate form from Dionex U.K. Ltd. and required a 1 in 4 dilution 
with ultrapure water.
(ii) Standard Preparation
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A 100 mg / L Stock Standard solution of each of the cations (Lithium, Sodium, Potassium, Magnesium, 
Calcium and Ammonium) were prepared by weighing 100 mg of the compound in its chloride form, 
dissolving with ultrapure water and diluting to a final 1 L volume.
(iii) Working Standards
1 , 5 , 1 0 , 15 and 2 0  ml of the stock solution were pipetted into 1 0 0  ml volumetric flasks and made up to the 
mark with ultrapure water.
(iv) Capillary Preparation: As per 3.3.1 (iv)
Each standard was injected three times using the operating conditions above for each electrolyte.
4.3.2 Results: Linear responses were observed for the DDP electrolyte. Interferences were obtained using 
the Copper Sulphate electrolyte, Non-linear responses attained using the phosphate electrolyte.
T
V
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Z
Diagram 4.1 Electropherogram of a mixture of 10 mg / L cation standards (Lithium, Sodium, Potassium, 
Magnesium, Calcium and Ammonium).
Conditions: 5 mM DDP Buffer, pH 4,5; UV Detection at 215 nm; Capillary: 50 cm x 50 pm i.d.; Voltage, 
20 kV; Gravity Injection 50 mm for 10 s.
4.4 IC Method Application
4.4.1 Materials and Operating Conditions
A previously reported method for analyzing cations by IC71 was used to examine interference and non­
linear response observed during CE analysis with the Copper Sulphate and Phosphate buffers.
Eluent 0 . 1 1  mM H2 SO4
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Sample 1-20 mg / L Li+, Na+, K+, Mg2+, Ca2+, N H /
Operating Conditions Cation-Exchange Column, Guard Column, Cationic Supressor Column
Flow Rate 1 ml / min
(i) Eluent Preparation
0.1051ml of AnalaR Grade Sulphuric Acid was accurately weighed and added to a large volume of 
ultrapure water. This was transferred to a 1 L volumetric flask and made up to the mark with ultrapure 
water. The eluent was filtered through a Gelman Acrodisc filter paper (0.45pm) and placed in the eluent 
container. Eluent was prepared fresh daily.
(ii) IC Operation
The system was purged with the eluent for 2 minutes. The flow rate was set at 1 ml / min. The cation- 
exchange column was allowed to equilibrate for approximately half an hour, until a stable background 
conductivity was obtained. Injections of ultrapure water were performed to ensure baseline stability. Once
a steady baseline was obtained injections of the cation standards were carried out.
(iii) Stock Solution
A 100 mg/L stock solution of each cation was prepared by weighing 100 mg of their chloride salt and 
dissolving in ultrapure water and diluting to 1 L in a volumetric flask.
(iv) Working Standards
1, 5, 10, 15 and 20 ml of the stock solution were pipetted into individually labelled 100 ml volumetric
flasks and made up to the mark with ultrapure water.
Each cation standard was injected three times.
4.4.2 Results: The elution order of inorganic cations followed results obtained in the previously reported 
method. It was decided to continue use of the DDP buffer for the initial determination of the first analyte, 
tromethamine.
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Diagram 4.2 Chromatogram of a mixture of 10 mg / L cation standards (Sodium, Ammonium, 
Potassium, Magnesium and Calcium).
Conditions: Eluent 0.11 M H2 SO4  ; Flow Rate 1 ml / min.
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CHAPTER FIVE 
TROMETHAMINE ANALYSIS
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5.1 Introduction
Nri2
h o h 2c  —  c  —  c h 2o h  
c h 2o h
Diagram 5.1 Tris (hydroxymethyl)aminomethane, (Tromethamine)
Tromethamine is a small inorganic molecule that is easily ionised and readily soluble in water72. It is 
commonly used as an alkaliser and emulsifying agent in pharmaceutical and cosmetic preparations73. It is a 
symmetrical molecule that consists of a central carbon atom attached to three -CH2OH groups and an -NH2 
group. The presence of these groups will determine the electrophoretic mobility of the analyte in the 
capillary. As tromethamine is a weak amine base, ionisation will take place within a narrow pH range 
above or below it’s pK value. Tromethamine has a pKb value of 7.872 at body temperature.
n h 3+ n h 2 n h 2
I I I
HO H2C —  C —  CH2OH «—  ► HOH2C —  C —  CH2OH 4 > HOHoC —  C —  CH2OH
l l .1
c h 2o h  c h 2o h  c h 2o ~
PH -  6.5 pH >6.5  pH > 6 .5
Diagram 5.2 Ionisation Mechanism of Tromethamine
At low pH the amino group acquires a net positive charge where the amino group is protonated and is 
reduced to -NH3+, while at higher pH values the -CH2OH groups becomes oxidised to CH20  '. 
Tromethamine is relatively non-complex and possesses no UV absorbing properties. Having considered its 
non-complex structure and known chemical properties, it was anticipated that the analyte would undergo 
electrophoretic mobility on the basis of charge to mass ratio in a charge environment.
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M atrix
Separation
Technique
Analysis 
Time (min)
Linear
Range
R2 L O D
Precision and 
A ccuracy
Recovery Ref
Opthalmiç
Solution
1C' 5-7 min
0.195-0.325 
mg /  mi
0.9998 - RSD=0.3-0.5% 100.5% 73
Tablet
UV-Vis
(Derivatisation)
-
20-100 
meg / mi
0.99977 20 meg / mi - 99.34% 74
Tablet Titration -
250 mg- 
500mg
- - - - 75
Tablet TLC - - - - - • 75
Tablet UV-Vis - 4-16pg / mi - - - 98.49% 75
Tablet HPLC 5 min
20-100 
¡.ig / mi
- - - 98.76% 75
Tablet,
Injection
HPLC 3.5 min
0.125-2.5 
ug / mi
- 0.2% 99.3-99.8% 99.7% 76
I.V. Fluid
UV-Vis
(Derivatisation)
>30 min
10-100
u g / ml
- 10 pg / ml 99.87% 77
H
O
9n>e—t-
g*
3
3a
</3.ôo'
5.2 
Literature 
Review 
for Trom
etham
ine 
A
nalysis
Matrix SeparationTechnique
Analysis
Time
Linear
Range
R2 LOD
Precision and 
Accuracy Recovery
Ref
Plasma HPLC (SPE) 7 min
25-2500 
ng / ml
0.9986 5 ng / ml RSD= 0.08%-2.2% 72.9-87.7% 78
Drug
Matrix
’■ UV-Vis >30 min
10-80 
pg / ml
0.9997 - - 98.52-100.26% 79
Opthalmic
Solution
HPLC 11 min
1-25 
pg / ml
0.99886 1 pg / mi RSD=0.05 101.103% 80
Plasma
HPLC
(Derivatisation)
15 min 1-25 p g / ml 0.997
0.282 pg /
mi
<16.4%
90.4-108%
90.4-101.2% 81
Plasma,
Urine
HPLC
(Derivatisation)
12 min
1-500 
pg / mi
0.9986-
00.9998
1 pg / mi RSD=0.3 8-0.99% 97.6-99.6% 82
Serum RP-HPLC 10 min
10-150 
ng / mi
0.9944 10 ng / mi 4.0%, 3.7% 92%
i
83
Injection
HPLC
(Derivatisation)
8 min
0.5-1.25 m g/ 
mi
0.9991 0.5 mg / mi 3.0% 101.2% 84
Ophthalmic
Solution
RP-HPLC 6 min 5-15 mg / mi 0.9998 - 2.0% 95.105% 85
Table 
5.1 
Trom
etham
ine 
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nalysis
Hall and co-workers73 have described the development of an Ion Chromatography method with 
conductivity detection for the determination of tromethamine in an ophthalmic solution. Using direct 
detection to avoid diminished performance, the elution of tromethamine was found at less than 5 min 
however the method suffered form interference from sodium ions that could only be resolved from the 
analyte peak at the expense of elution time. It is evident from the procedure that the method induced a 
significant loss in column efficiency due to the build up of the cation on column.
A complexation reaction between KT and p-dimethylamino benzaldehyde in concentrated HC1 was
necessary for the spectrophotometric determination of the drug in a pharmaceutical dosage form74,
however the complex generated was chemically unstable as it degraded within 24 h, even though the
method achieved recoveries of approximately 99.34%. Sane et al.75 developed a non-aqueous titration
method, thin-layer chromatographic (TLC) method, UV and RP-HPLC for the detection of KT in a bulk
pharmaceutical form were developed and compared. They found that the non-aqueous titrimetric method
provided linearity only in the range 250 mg to 500 mg of the drug while the UV method required
derivatisation, the RP-HPLC system involved the use of an internal standard while the separation of KT
from its impurities was only partially successful for TLC. Various other methods76'77 have been developed
for the investigation of tromethamine in tablets and urine however strict control of experimental conditions
was essential to ensure adequate precision and accuracy. The spectrophotometric evaluation of
tromethamine was achieved by reaction of the analyte with ortho-phthalaldehyde in alkaline medium in the
presence of a reducing agent that was specific only for detection in intravenous fluids.
Tromethamine has been analysed previously in its ketorolac form that has been demonstrated to be
effective in the management of acute pain as well as in the improvement of ocular inflammation78. This
procedure reported by Sola et. al. involves the development and use of an automated solid phase extraction
method for the determination of ketorolac tromethamine (KT) in human plasma using HPLC. The method
describes a lengthy extraction procedure and the use of an internal standard for quantitation. The method
suffers from poor precision and accuracy at low KT concentration low recoveries from plasma samples
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approximately 73%. Ketorolac has also been analysed by colorimetry and HPLC80 in an ophthalmic 
solution and by charge transfer and ion pair complexation reactions in which reaction with various 
reagents was required. The charge transfer procedure suffered from poor sensitivity as the ion pair 
preparation method was inconvenient and time consuming. Gumbhir and Mason81 also attempted the 
derivatisation of tromethamine by reaction with benzoyl chloride and subsequent analysis by GC. 
Derivatisation was achieved via reaction of the molecule with the UV absorbing chromophore by first 
reacting with acid chloride in the presence of a base and subsequent generation of the benzoylated 
derivative. The GC method reported uses UV/vis detection, These authors describe an extraction procedure 
prior to analysis o f the derivative that proved suitable only for tromethamine determination in specific 
bodily fluids. Morris and Hsieh82 detected tromethamine in human plasma and urine using fluorescence 
detection however an additional derivatisation step was required. Analysis of tromethamine has been 
accomplished by several analytical methods. Early reports describe the use of colorimetry86 in the 
evaluation of tromethamine. This involves a diazotisation reaction coupled with a coupling procedure, and 
the use of boiling sulphuric acid. Gas Chromatography (GC)87 methods were developed subsequently in 
which derivatisation reactions were required. Vincent et al.88 derivatised tromethamine for GC analysis 
where the three hydroxy groups were converted to their corresponding silyl derivatives however the 
derivatised products were unstable and therefore the procedure was deemed inconvenient for incorporation 
as a routine analytical method. Omission of extraction and derivatisation steps would speed up analysis. 
Other spectrophotometric methods also require derivatisation procedures.
5 .3 Method Development
5.3.1 Choosing an Electrolyte
The first electrolyte system chosen for determining a response for tromethamine was a Copper Sulphate 
electrolyte. This buffer determined the NH4+ cation as described in Section 4.3.2. The CE method used 
however suffered from interference, but not at the migration time of the ammonium ion, thus it was
thought that a response would also be generated for tromethamine at a similar migration time.
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5.3.1.1 Copper Sulphate
Electrolyte: 4 mM Copper (II) Sulphate, 4 raM Formic Acid, 4 niM 18-Crown-6-Ether, pH 5
Sample: 20 mg / L tromethamine
Operating Conditions: As per Section 4.3.1 
Electrolyte Preparation: As per Section 4.3.1
(i) Stock Standard Solution
0.0989g of tromethamine solid (99.8% pure) was accurately weighed and dissolved in ultra pure water. 
The solution was transferred to a 1 L volumetric flask and diluted to the mark with ultrapure water.
(ii) Working Standard
20 ml of the stock solution was pipetted into 100 ml volumetric flasks and diluted to the mark with 
ultrapure water.
Result: A response appeared at approximately 5 min, however other peaks were present in each 
electropherogram.
Subsequent standards of tromethamine were prepared and injections performed.
Working Standard
1, 5, 10, 15 and 20 ml of the stock solution was pipetted into 100 ml volumetric flasks and diluted to the 
mark with ultrapure water.
Result: Responses occurred at approximately 5 min. Peaks recorded increased in height and area upon 
increasing concentration injected.
Diagram 5.3 Calibration Plot of Tromethamine using Copper (II) Sulphate Electrolyte
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An unacceptable linear response was obtained in the calibration plot o f concentration v peak area however, 
a correlation coefficient of R2=0,9601 was obtained from a plot of concentration v peak height, (n=3).
Using the above electrolyte system the occurrence of peaks at approximately 2.5, 3, 3.5 and 10 min also 
appeared with each injection. Large peak areas were observed when 20 mg/L tromethamine standards were 
injected, thus it was thought that concentrations above 15 mg/L deviated form linearity. Linearity was 
further investigated in the 5-10 mg/L concentration range to improve the correlation coefficient values and 
results indicate significant variations from those obtained previously. Upon repeating injections (5-10 
mg/L), non-linear responses were demonstrated. Together with the persistent presence of unknown peaks 
and unacceptable linearity, it was decided to choose a more suitable electrolyte system.
5.3.1.2 Imidazole
Imiadzole-Acetic Acid electrolyte has been previously reported for the analysis of inorganic cations.68,89'92 
Imidazole possesses strong UV absorbing properties and is structurally similar to the analyte of interest. 
Imidazole was chosen for this investigation as it is thought it would have similar electrophoretic mobility 
to tromethamine.
Electrolyte: 5 mM Imidazole, 1 M Acetic Acid, pH 5
S ample: 10- 5 0 mg / L tromethamine
Operating Conditions As per Section 4.3.1
(i) Electrolyte Preparation
Imidazole (4.0098g) was accurately weighed, dissolved in ultrapure water and transferred to a 1 L 
volumetric flask and made up to the mark. Electrolyte pH was adjusted using 1 M Acetic Acid.
(ii) Stock Solution As per Section 5.3.1.1
(iii) Working Standards: As per Section 5.3.1.1
Working standards were diluted in electrolyte in an attempt to remove unknown peaks observed in Section 
5.3.1.1.
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Result: Responses occurred at approximately 5 min. Peaks still remained at approximately 2.5, 3, 3.5 and
10 min with each injection. Below 10 mg / L sample no detector response was observed. Peak splitting
was observed at higher concentrations.
Due to poor results obtained with imidazole-acetic acid electrolyte, it was decided to examine the effect of 
adding 18-Crown-6-Ether. Crown ethers have been added in previous studies CE analysis65,68*70’91 and it 
was hoped that this compound would complex with unknown peaks in the system.
Electrolyte: 5 mM Imidazole, 5 mM 18-Crown-6-Ether, 1 M Acetic Acid, pH 5
Sample: 10-50 mg / L T romethamine
Operating Conditions: As per Section 4.3.1
(i) Electrolyte Preparation
Imidazole (4.0098g) and 0.52721g of 18-Crown-6-Ether were accurately weighed, dissolved in ultrapure 
water and transferred to a 1 L volumetric flask and made up to the mark. Electrolyte pH was adjusted to 
pH 5 with 1 M Acetic Acid.
(ii) Stock Solution: As per Section 5.3.1.1
(iii) Working Standards: As per Section 5.3.1.1
Result: Inclusion of the complexating agent did not remove unknown peaks. Responses at 5 min were still 
the same.
Electroosmotic Flow:
The flow of neutrals in the system was determined by injecting 2-naphthol to investigate whether the EPM 
and EOF had similar mobility using these conditions. Approximately 2g (5 mM) was weighed accurately 
and dissolved in methanol. EOF was apparent at approximately 10 min.
Cation standards prepared as per Section 4.3.1 were injected onto this system. Peaks were identified as K+, 
(2.4 min), Ca2+ (2.96 min) and Na' (3.48 min).
As a result of satisfactory outcomes using DDP as electrolyte for the determination of cations by indirect-
UV detection, this was the next electrolyte of choice.
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Dimethyldiphenylphosphonium Iodide Buffer (DDPI)
DDPI has been used in the analysis of a wide variety of cations from simple alkali metals to transition 
metals52,94. It is reported that the mobility of the electrolyte is similar to metal ions Li ' , Na+, Mg2+’ Ca2+ 
and K+, resulting in high peak efficiencies and good peak shapes. Indirect photometric detection was used 
as the DDPI compound acted as the UV absorber. In order to determine the most appropriate wavelength 
to use in the CE, UV spectrophotometric scans of DDP were obtained.
(i) Stock Electrolyte Solution
A Stock Solution of DDPI (0.2 mM) was prepared in ultrapure water by weighing 0.0612g of the solid, 
dissolving in ultrapure water, transferring to a 100 ml volumetric flask and making up to the mark with 
ultrapure water. An absorbance reading against a water blank was taken. Serial dilutions of the stock 
solution were made by pipetting 1-50 ml, transferring to 100 ml volumetric flasks and making up to the 
mark with ultrapure water. Corresponding absorbance values were read.
5.3.1.3 DDP
Diagram 5.4 (a) UV Spectrophotometric Scans of DDP
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(b) Calibration Plot ofDDP (Electrolyte Concentration v UV Absorbance)
Result: DDPI was found to have a molar absorptivity of 1.65 x 105 mol'1 dm2 at a wavelength of 215 nm. 
DDPI-18-Crown-6-Ether-a-hydroxyisobutyric Acid
In previous studies52,94 DDPI has been used with 18-Crown-6-Ether and a-hydroxyisobutyric acid thus the 
electrolyte was prepared using these methods.
Electrolyte 5 mM DDP, 6 mM a-hydroxyisobutyric acid, 8 mM 18-Crown-6-Ether pH 4.6
Sample: 1-5,10-50 mg / L tromethamine
Operating Conditions: As per Section 4.3.1
(i) Electrolyte Preparation
A stock solution of DDPI (25 mM) was prepared by weighing 0.8854g of the compound, dissolving in 
ultrapure water and making up to a final 100 mL volume. A stock solution of 18-Crown-6-Ether (40 mM) 
was prepared by weighing 1.057g of the compound, dissolving with ultrapure water and making up to a 
final 100 mL volume. A stock solution of a-hydroxyisobutyric acid (100 mM) was prepared by dissolving 
1.041g of the compound in ultrapure water, transferring to a 100 mL volumetric flask and making up to the 
mark.
DDP electrolyte was purchased from suppliers in its iodide form. By solid phase extraction, this solution 
was converted to its corresponding hydroxide form by the following method.
(ii) Solid Phase Extraction (SPE)
Conditioning of the SPE cartridge was carried out as follows: 10 ml of NaOH (1 M) was passed through an 
On Guard A Cartridge, followed by 10 ml ultrapure water at a rate of 2 ml / min. 10 ml of the DDPI stock
61
solution was then passed through the cartridge, the first 2 ml was discarded. To a 100 ml volumetric flask 
was added the remaining 8ml of the converted DDPI solution, 5 ml of the 18-Crown-6-Ether solution and 
6 ml of the a-hydroxyisobutyric acid solution. The mixture was made up to the mark with ultrapure water.
CeHs (CH3)2 PHa I C a H s  *  C6H5 (CH^  PH30H
DDPI DDP
Diagram 5.5 DDPI converted to DDPOH
(iii) Stock Standard Solution As per Section 5.3.1.1
(iv) Working Standards As per Section 5.3.1.1
Result: Responses occurred at less than 5 min. Detector responses generated symmetrical peaks without 
interference.
I
Diagram 5 .6 Initial Tromethamine Response
Calibration graphs constructed for injections 1 - 5 mg / L tromethamine, at n = 3, indicated good linearity 
with correlation coefficient 0.9984 for average peak height. Injections of tromethamine (10-50 mg / L) 
were then performed to examine linearity at higher concentrations. Calibration plots constructed (10-50 
mg / L) displayed linearity with a correlation coefficient = 0.9999.
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12
y = 2.C42x 1,942 
R2 = 0S984
(a) (b)
SO
Diagram 5.7 Calibration Plot of (a) 1-5 mg / L and (b) 10-50 mg / L Tromethamine
DDPI electrolyte was found to be the most suitable for the analysis of the analyte as peak shape appeared
to be much improved compared to previously used electrolytes. The function of the crown ether in the
buffer was next examined as injections of ultrapure water and electrolyte alone did not generate peaks 
(identified in Section 4.4.1) as before in Section 5.3.1.2.
Result: No difference was observed from results collected with or without 18-crown-6-ether, thus it was 
decided to omit the inclusion of the complexating agent from all further analysis.
5.3.2 Electrolyte pH Variation
The pH of the electrolyte was varied to examine its effect on the electrophoretic mobility of the analyte.
Electrolyte 5 mM DDP, 6 mM a-hydroxyisobutyric acid, pH 3-11
Sample: 20 mg / L tromethamine
Operating Conditions: As per Section 4.3.1
Electrolyte Preparation:
A Stock Solution of DDPI (25 mM) was prepared by weighing 0.8862g of the compound and dissolving in 
ultrapure water and making up to a final 100 mL volume. A Stock Solution of a-hydroxyisobutyric acid 
(100 mM) was prepared by dissolving 1.039g of the compound in ultrapure water, transferring to a 100 mL 
volumetric flask and making up to the mark.
(ii) Solid Phase Extraction (SPE): As per Section 5.3.1.3
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By adding various amounts of a-hydroxyisobutyric acid dropwise to the electrolyte, a range of pH values 
were obtained. Electrophoretic and electroosmotic mobility were monitored in the range pH 3-11. EOF 
was measured by injecting 2-naphthol (prepared as before).
Result: Optimum mobility can be observed at pH 5.2, Table (i).
Etecttolyc* c  pH
Diagram 5.8 DDP pH v (a) Electrophoretic and Electroosmotic Migration and (b) Electrophoretic 
Mobility
Analyte mobility was apparent only in the narrow pH range 3.5-6.5, Table (ii), Appendices. The 
electroosmotic flow was retarded at low pH values whereas at higher pH values the flow of the bulk 
electrolyte was rapid throughout the capillary. Tromethamine is therefore uncharged in this alkaline 
environment, pH > 6.5 and is detected as a cationic species in acidic conditions, pH > 3.5. Electrolyte pH
5.2 was used for all further analysis.
5.3.3 Voltage Variation
The operating voltage was varied from 15 kV to 25 kV, Table (iii), Appendices, to examine the effect of 
electrophoretic and electroosmotic mobility. Voltages above 20 kV required the application of a cooling 
jacket. The resulting current and observed power generated were monitored from the display screen on the 
CES instrument, placing a thermometer inside the hood of the instrument monitored temperature variation. 
A 20 mg / L standard was used to examine electrophoretic mobility and electroosmotic mobility monitored 
upon injections of 2-naphthol. -
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Diagram 5.9 Applied Voltage v Migration of Tromethamine and 2-Naphthol
Result: Increased electrical application is seen to enhance electrophoretic and electroosmotic mobility 
whereby analysis time is reduced by approximately 2 min. An optimum voltage of 20 kV was chosen.
5.3,4 Temperature Variation
A thermometer was placed on the inside of the hood. Injections of 20 mg / L tromethamine standard were 
performed at extreme temperatures.
3
Diagram 5.10 Electrophoretic Mobility v Temperature
As the instrument did not have an automated temperature control system, thermometer readings, were 
taken early in the morning when average temperatures were 15°C, early in the afternoon when laboratory 
humidity was highest and temperatures averaged 23.5°C and finally, late at night when laboratory 
temperature was reduced, Table (iv). Injections were performed at various temperatures, readings collected 
over three days and results averaged.
Result: Electrophoretic mobility is most significant at 20°C and less significant at 17°C.
5.3.5 Ionic Strength Variation
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A series of electrolyte concentrations were prepared to examine the effect of variation of ionic strength on 
migration time of 20 mg / L tromethamine.
(i) Ionic Strength Concentrations
To a series of labelled 100 ml volumetric flasks were added 8, 4, 2, 1 and 0.5 ml of the converted DDPI 
solution and 6 ml of a-hydroxyisobutyric acid (As per Section 5,3.1.3) to a final pH 4. The mixture was 
made up to the mark with ultrapure water. Final buffer concentrations were 5 mM, 2.5 mM, 1.25 mM, 
0.625 mM and 0.312 mM.
Result: Analyte migration increases from 3 min to approximately 5 min upon reducing ionic strength in the 
range examined, Table (v). Concentrations above 5 mM DDPI were not examined as too much heat was 
generated inside the capillary and the system automatically shut down. An ionic strength of 5mM 
electrolyte was used for all further analysis.
Diagram 5.11 Concentration DDP v Tromethamine Migration
5.4 Method Validation
5 .4.1 Linearity Linear Range and Limit of Detection
Linearity of the method was determined initially between 1-5 mg / L followed by 10-50 mg / L 
tromethamine.
(i) Working Standards
1, 2, 3, 4 and 5 ml and 10, 20, 30, 40, 50 and 60 ml of the Stock Solution were pipetted into 100 ml 
volumetric flasks and made up to the mark with ultrapure water. Each standard was injected three times.
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Result: The method provided linearity in the range 2.5 mg / L to 25 mg / L. The lowest operating limit of 
detection was found to be 2.5 mg / L, as responses below this concentration remained relatively constant 
and independent of changing concentrations. At higher concentrations, deviations from linearity were 
observed in excess of 25 mg / L where line plateau was evident, Table (vi). Calibration curves were 
compiled from data generated upon injection of 2.5 mg / L - 25 mg / L standard solutions where n = 5. y = 
0.098x - 0.029, R2=0.9992. The sensitivity of the system was found to be 0.98 absorbance units / mg.'1
Diagram 5.12 Calibration Plot Tromethamine
5.4.2 Repeatability
The repeatability of the method was examined by injecting ten samples of 10 mg / L tromethamine 
solutions from similar and different carousel vial positions to ascertain variability between injections.
Result: Standard Deviation and Relative Standard Deviation were calculated from peak height and found 
to be 0.14% and 2.01% respectively for injections from the same vial position and 0.36% and 3.43% 
respectively for injections from different vial positions.
5.4.3 Precision and Accuracy
The precision and accuracy of the method was determined by conducting intra- and inter-assay variability
tests. The intra-assay variability test consisted of analyzing five concentrations of each standard, 5 to 25
mg / L and injecting each standard six times in one batch, Table (vii). The amount of tromethamine in
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each standard was plotted against the average peak height to determine the correlation coefficient. Results 
from four different intra-assay variability tests, collected over four days were used to find the % coefficient 
of variation and % deviation.
Result: Over the concentration range studied the average RSD was found to be 0.42% and the average 
deviation was found to be 1.62%. The average deviation is inflated owing to the relatively poor deviation 
obtained for the concentration of 5 mg / L. The remaining four concentrations gave an average of 0.94%. 
As the concentration of the sample is 12 mg ml'1, the result is acceptable.
5.4.4 Specificity
The specificity of the method was examined by comparing the response from injections using standard 
tromethamine and a placebo solution to examine matrix effects. The placebo solution contains other 
ingredients such as Polyhexamethylene Biguanide, Tromethamine, Disodium EDTA and Tyloxapol. 
Injection of the placebo were made (n=3).
Result: A steady baseline was obtained when placebo solutions were injected. This suggests that the 
method developed is specific for the determination of tromethamine. Recovery studies were therefore 
conducted.
5.4.5 Recovery Studies
Recovery of the method was applied for the determination of tromethamine in a pharmaceutical product 
‘Complete’, containing 12 mg ml'1 tromethamine.
(i) Spiked Placebo Solutions
Stock solutions of spiked placebo were prepared as follows. 5, 10, 15, 20 and 25 mg of tromethamine were 
accurately weighed and dissolved in the placebo. A 1 in 1000 dilution of each of the spiked solutions was 
made using ultrapure water to generate a series o f placebo solutions containing 5, 10, 15, 20 and 25 mg / 
L. Six injections of standard tromethamine solutions and six injections of spiked placebo solutions were 
performed.
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CHAPTER SIX 
OXYTETRACYCLINE ANALYSIS
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As the method for determining tromethamine using indirect photometric detection was developed and 
validated, it was decided that another method using direct photometric detection could also be 
developed and validated. The aim of this investigation was to develop a CE method using direct 
photometric detection for the analysis of oxytetracycline (OTC).
The pKa values of OTC are 3.27, 7,32, 9.11 and 10,7. The presence of a hydroxyl group at C-6 enables 
acid degradation to 4-epioxytetracycline (EOTC) through an equilibrium reaction, and to 
anhydrooxytetracycline (ADOTC) by irreversible dehydration.
6.1 Introduction
Diagram 6.1 Structure of Oxytetracycline
OTC is a broad spectrum antibiotic of the family of tetracyclines which are used to control bacterial 
infections in both humans and animals. OTC is found in a variety of pharmaceutical products for human 
and veterinary use. OTC is commonly found in topical ointments used in dermatology therapy. OTC has 
also been added to animal feed in order to control lice infestations on the animal’s skin. The use of 
oxytetracyline in animal feed to control animal disease leads to problems with residues in medicated 
fish and in the environment. The use of oxytetracyline may result in residues being present in animal- 
derived food products and these residues pose a health threat to consumers. Oxytetracyline has also 
found applications in the preservation of harvested fruits and vegetables.
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6.2 Literature Review
HPLC methods95,96 have been developed for the analysis o f OTC from fish samples of skin, muscle and 
tissue. Sample preparation involves a number of steps including spiking with internal standard, 
extracting, shaking, sonication, centrifugation, filtration, dilution followed by extraction with C18 and 
C8 Bond Elut SPE columns, prior to analysis by HPLC. Even though analysis times are less than 5 min, 
these methods suffer from low recoveries, 89-95%. A CE method for determining OTC from its 
impurities97 in a pharmaceutical product has been described. Triton-X-100 and methyl-3-cyclodextrin 
were required to separate OTC from another tetracycline, demeclocycline. Analysis time for OTC was 
measured at 17 min. Electrolyte pH was restricted to the alkaline region to avoid sample adsorption onto 
the capillary wall and OTC could not be resolved completely from its impurity ADOTC. CZE 
techniques98,99,100 report the detection of OTC from pharmaceutical and biological samples. OTC is 
reported to easily complex with metals and thus this was the basis for the non-aqueous CZE technique98 
using laser-induced fluorescence detection. Metal complexation was reported to obtain separation 
selectivity. The non-aqueous CE method99 demonstrates the separation of OTC from its degradation 
products as metal chelates with magnesium ions. The electrolyte was magnesium acetate tetrahydrate 
with NMF, This organic solvent was found to harm the material of the lever arm of the instrument and 
parts of the injection system had to be cleaned and trimmed due to leaks resulting in variations of 
injection pressure.
The separation and characterisation of OTC and other tetracycline products has been reported by 
Tavares and McGuffin.100 A recovery of 95% was obtained from a tablet matrix in approximately 5 min. 
Acid-base equilibrium constants were determined for each of the tetracyclines analysed. Low recoveries 
were also reported101 for the analysis of OTC from milk samples with HPLC. The matrix also contained 
tetracycline and chlortetracycline and the authors report difficulty optimising separation of OTC from 
these. An isocratic RP-HPLC method102 was also unsuccessful in isolating OTC from its degradation
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impurities. An MECC technique103 using 50 mM borate, 50 mM phosphate and 10 mM SDS at pH 8.5 
successfully resolved OTC from its impurities however analysis time was 13.3 min. CZE104 has detected 
OTC at 4.5 min using 20 mM sodium carbonate electrolyte with 1 mM EDTA. The method however is 
less selective than other reported HPLC methods. CE has also been used to detect OTC in a 
pharmaceutical105 and biological matrices.106 The CEC105 method involved etching the inner wall o f the 
capillary surface and modifying with a silation/hydrosilation reaction in order to attach a C l8 moiety. 
The CZE method106 determined OTC in 11 min however sample preparation was complex. Three HPLC 
methods107'109 have determined OTC from milk and environmental samples with recoveries 
approximately 80%. Analysis times range from 4.5 min to 12 min and methods are not selective for 
OTC in each of the respective matrices. The IC determination110 of OTC has also been reported for its 
determination in milk and milk powder. OTC has been resolved from other tetracyclines in the matrix 
using a cation exchange column. It was necessary to use an organic solvent, ACN, in this technique to 
facilitate sample suolubility and column cleanup.
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Matrix
Separation
Technique
Analysis 
Time (min)
Linear
Range
R 2 LOD Precision and Accuracy Recovery Ref
Fish Tissue
HPLC
(SPE) 3.1-3.4 min 0.2-10 fig/m 1
0.9991 0.05 |-ig/ml RSD=0.8-1.0% 91.3%
95
Fish Tissue
HPLC
(SPE) 5 min 10-20 ug/ml 0.978 5 ng/g
RSD=4.2% 89.3-94.8% 96
Antibiotics
CZE 17 min
0.25-1.75
Pg/ml
0.9994 0.05 ¡ig/ml 97
Milk, Plasma
CZE 13 min
50-1000
ng/ml 0.999 25 ng/ml
RSD=3.6% 97.2% 98
Ointment
CZE 14 min 0.2-3 mg/ml 0.999 0.2 mg /ml 100% 99
Tablet
CZE 5.41 min 0.9989 1x 10'5M 95% 100
Milk HPLC 4 min
100-3200
ng/ml
0.982-
0.996 100 ng/ml RSD= 1-9.3% 63.5-93.3% 101
RP-HPLC 8 min 0.9998 0.05% RSD=0.3% 92.7% 102
Table 
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6.3 Method Development
6.3.1 Solubility of OTC
Oxytetracycline is an amphoteric compound with high polarity and an isoelectric point between 4 and 
6.110 Therefore, as it was insoluble in ultrapure water it was necessary to establish solubility data. 
Sample preparation: 100 mg of Oxytetracycline Dihydrate was accurately weighed and placed in a 50 
ml b eaker. 20 ml of each solvent was pipetted into the beaker, The solution was mixed with a glass rod 
and resultant appearance recorded.
Solvent Preparation: (a) Dilute Acid Solution: 36.54g of concentrated Hydrochloric acid was weighed 
and added to a large volume of ultrapure water in a 1 L beaker. The solution was transferred to a 1 L 
volumetric flask and made up to the mark with ultrapure water, (b) Dilute Alkali Solution: 40.010g of 
Sodium Hydroxide pellets were accurately weighed and added to a large volume of ultrapure water 
contained in a 1 L beaker. The solution was mixed with a glass rod and transferred to a 1 L volumetric 
flask and made up to the mark with ultrapure water.
Result: Methanol and dilute acid were selected as sample solvent for further investigations.
Table 6.2 Oxytetracycline Solubility Data
Solvent Solubility Appearance
Methanol Readily Soluble Clear
Ethanol Insoluble Opaque yellow suspension
Propanol Insoluble Opaque yellow suspension
Butanol Insoluble Opaque yellow suspension
Pentanol Insoluble Opaque yellow suspension
Acetonitrile Sparingly soluble Opaque yellow suspension
Tetrahydrofuran Sparingly soluble Opaque yellow suspension
1 MHC1 Readily soluble Clear
1 MNaOH Readily soluble Clear
6.3.2 UV Measurements
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UV absorbance measurements of OTC were recorded in order to ascertain its maximum wavelength of 
absorbance.
(i) Stock Solution Preparation
A 1000 mg / L stock solution was prepared by weighing O.OlOg of OTC Dihydrate, dissolving in 
Methanol and transferring to a 100 ml volumetric flask. The solution was made up to the mark with the 
solvent.
(ii) Working Standard Solutions
1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 ml of the stock standard solution were pipetted into 100 ml volumetric 
flasks labelled 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 mg / L OTC. The solutions were made up to 
the mark with methanol.
Methanol was placed in the UV Spectrometer and a background reading taken. Absorbance readings for 
each of the standard OTC solutions were read.
Wavelength
Diagram 6.2 UV Scans of OTC
Result: The maximum wavelength of absorbance is 270 ran,
6.3.3 Choosing a Suitable Electrolyte:
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Tris-HCl buffers have been previously reported for the analysis of OTC104,105 therefore this electrolyte 
was used to determine an initial response. The pH of the electrolyte was maintained neutral to avoid 
degradation. Injections of 100 mg / L OTC and 2-naphthol (5mM) were made to examine 
electrophoretic and electroosmotic behaviour.
Electrolyte 50 mM Tris-HCl, pH 7
Sample 100 mg / L OTC in Methanol, 2-Naphthol
Operating Conditions Capillary Dimensions 50 jam (i.d.) x 50 cm (1) x 375 p,m (o.d.)
Detection System UV, at 270 nm
(+), Detector side Cathodic 
Constant Voltage, 20 kV 
Gravity, 100 mm for 30 sec 
Ambient
Polarity 
Control Mode 
Injection 
Temperature 
(i) Electrolyte preparation
6.059g of tromethamine was weighed and dissolved in ultrapure water in a 50 ml beaker. This solution 
was transferred to a 1 L volumetric flask and adjusted from pH 10.4 to pH 7 using the previously 
prepared 1 M dilute HC1 solution. The solution was made up to the mark with ultrapure water.
The stock standard, working standard, naphthol solution and capillary were prepared as in Section 6.3.2.
Diagram 6.3 Initial OTC Response
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Result: A response appeared at approximately 3.5 min showing two reponses eluting together. 
Electroosmotic mobility at approximately 3 min however peak shape was poor.
Initial detector responses indicate peak efficiency was poor as peak shapes were asymmetric thus the 
sensitivity of the detector was low. Attempts were made to improve peak efficiency by optimising UV 
wavelength used, changing the sample solvent and increasing sample injection volume.
6.3.4 Optimising UV Absorbance
The output signal generated from the detector was examined to see which wavelength would give the 
greatest response. Injections of 100 mg / L OTC were performed at wavelengths 270 to 210 nm.
Result: The greatest detector response was at 210 nm. Peak Height readings were not recorded due to 
poor peak shape as the sample solvent used was methanol. Satisfactory agreement has been reached 
upon detector output in terms of peak area as these remain relatively constant regardless of peak shape. 
From results obtained it can be seen that as the operating wavelength decreases there is a steady 
decrease in electrophoretic mobility in the system. This may be due increased absorption of water near 
210 nm. A UV wavelength of 210 nm was chosen for all further analysis.
6.3.5 Changing Sample Solvent
100 mg / L standard OTC solution was dissolved in previously prepared 1 M HC1, 0.1 M HC1, 
electrolyte. Injections of 100 mg / L were made using the conditions above to investigate if peak shape
I <=, -1
Diagram 6.4 OTC Response with Electrolyte as Solvent
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Result: The best sample solvent is electrolyte as the peak shape has significantly improved.
6.3.6 Varying Injection Volume
Detector sensitivity was low because greater peak height and area readings were obtained for much
smaller concentrations during tromethamine analysis. By increasing the volume of sample injected onto
the capillary, the output signal from the detector can be increased. Programming the instrument to raise
the head height and inject for longer periods, increased the volume of sample loaded onto the capillary.
Injections of 0.142 nl, 0.852 nl, 1.704 nl, 2.13 nl and 2.556 nl o f 200 mg / L OTC were performed.
Sample volumes were calculated using the equation:
V = 2 .84x10 * H T D  (Eqn6.1)
L
where, V  = Volume injected (nL), H  = Head height (mm), T  = Injection time (sec), D = Internal capillary Diameter (m) and 
L = Total capillary length (cm).
Result: An injection volume of 1.704 nl was chosen for further analysis as this volume produced the 
greatest detector signal.
The optimum operating UV wavelength was found to be 210 nm, sample solvent was electrolyte and 
optimum injection volume used a head height of 100 mm and injection time of 40 sec. Once these 
parameters were chosen, it was possible to examine the electrolyte pH and composition.
6.3.7 Electrolyte pH Variation
The pH of the electrolyte was varied to examine the effect on the electrophoretic and electroosmotic 
mobility of the analyte.
(i) Electrolyte Preparation as per Section 6.3.3
For each pH value, 200 ml of the electrolyte was pipetted into a beaker and 2 M HC1 was added drop 
wise with a Pasteur pipette to generate a series of pH values.
(ii) Capillary Conditioning
The capillary was washed sequentially with 1 M NaOH for 10 min, ultrapure water for 15 min followed
by capillary conditioning with run buffer for 30 min upon application of each pH buffer systems.
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Electrophoretic mobility (pep) was calculated by injecting 200 mg / L OTC, n -  3.
Diagram 6.5 Migration of OTC v Electrolyte pH
Result: At high pH>10, electrophoretic and electroosmotic mobility flow through the capillary has 
increased however peak shape has deteriorated, Table (viii), At pH 3-7, peak splitting was obvious and 
the response due to OTC was no longer apparent. It is thought that acid degradation of the sample may 
have occurred inside the capillary. From initial investigations, electrolyte at pH 7 indicated acceptable 
peak shape in reasonable migration time, thus this pH was chosen for all further analysis.
6.3.8 Ionic Strength Variation
(i) Electrolyte Preparation: A series of electrolytes of varying Tris concentration (10, 20, 30, 40, 50, 60, 
and 70 mM) were prepared by dissolving 1.210g, 2.422, 3.632g, 4.843g, 6.059g, 7.264g and 8.475g of 
the compound in ultrapure water in a 50 ml beaker. Each solution was adjusted to pH 7 with 1 M HC1 
and transferred to labelled 250 ml volumetric flasks. The resulting solutions were made up to the mark 
with ultrapure water.
(ii) Capillary Conditioning: As per Section 6.3.3
6.3.9 Electrophoretic and Electroosmotic Mobility
The electrophoretic mobility was examined by injecting 200 mg / L OTC and recording the migration 
time obtained with each buffer concentration. The electroosmotic mobility was calculated by injecting
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of 5 mM 2-naphthol solution prepared as before. Current and temperature readings were taken 
throughout. The resulting current was read from the CES screen and temperature fluctuation was 
monitored by placing a thermometer inside the hood of the instrument.
Diagram 6.6 Electrolyte Concentration v Migration Time
Result: From graphs constructed of electrolyte concentration v electrophoretic and electroosmotic 
migration, analysis time for OTC is reduced by 2 min upon decreasing ionic strength from 70 mM to 10 
mM, Table(ix). The reduction in migration for the EOF is not as significant. Therefore electrolyte ionic 
strength using 10 mM Tris was employed for all future procedures.
6.3.10 Electrolyte Composition
The composition of electrolyte was altered as previously reported methods103'106 have explored the 
effect of adding organic solvents and surfactants to buffer systems in tetracycline analysis to resolve 
similar chemical structures. It was decided to add methanol and sodium dodecyl sulphate to establish 
the overall effect on electroosmotic and electrophoretic mobility within the CE system.
6.3.10,1 Addition of Methanol
(i) Electrolyte Preparation
1.21 lg  of Tris was weighed and dissolved in ultrapure water in a 50 ml beaker. This solution was 
transferred to a 1 L volumetric flask and adjusted from pFI 10.4 to pH 7 using 1 M dilute HC1 solution. 
The solution was made up to the mark with ultrapure water. 60, 70, 80, and 90 ml of the electrolyte
82
solution were pipetted into 4 x 100 ml beakers. 10, 20, 30 and 40 ml of methanol were pipetted into 
each of 100 ml beakers containing the electrolyte solution ensuring 10- 40% (v/v) methanol was 
contained in each.
(ii) Capillary Conditioning: As per Section 6.3.3
Diagram 6.7 Effect of Adding Methanol to Electrolyte
Result: As analysis time has significantly increased it was decided not to add methanol to the 
electrolyte.
6.3.10.2 Addition of Sodium Dodecyl Sulphate (SDS)
(i) Electrolyte Preparation: As before
4 x 100 ml of the electrolyte solution were pipetted into 4 x 200 mL beakers. 10, 20, 30, 40 mM SDS 
were weighed and added to each of the electrolyte solutions and stirred using a glass rod.
(ii) Capillary Conditioning:
The capillary was washed sequentially with isopropanol for 30 min, ultrapure water for 15 min, 1 M 
NaOH for 10 min and rinsed again with ultrapure water for 15 min. The capillary was equilibrated with 
run buffer for 30 min upon application of each new electrolyte system.
200 mg / L standard OTC solution prepared as before was injected three times.
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Diagram 6.8 Effect of Adding SDS to Electrolyte
Result: Analysis time has increased by 5 min. Concentrations of SDS above 40 mM caused excessive 
build up of current in the capillary that could not be efficiently dissipated and initiated the automatic 
shut down system. No real advantage was offered for the addition of SDS.
6.3.11 Voltage Variation
The operating voltage was varied from 15 kV to 25 kV to examine its effect on the speed of analysis, 
Table (x). Voltages above 20 kV required the application of a cooling jacket. The resulting current was 
monitored from the display screen on the CES instrument.
Diagram 6.9 Applied Voltage v Migration Time
Result: High voltages reduce electrophoretic and electroosmotic mobility in the capillary. 
Electrophoretic mobility is affected to a greater extent then the electroosmotic mobility as the analysis 
time is reduced by over 5 min as the applied voltage is increased from 15-25 kV. Change in the
migration of the neutral species was substantially less and amounted to less than 3.5 min over the 
applied voltage range. Optimum voltage chosen from an Ohm’s Law Plot of 25 kV was used for all 
further analysis.
6.4 Method Validation
6.4.1 Linearity, Linear Range and Limit of Detection
(i) Stock Standard Solution: As per Section 6.3.3
(ii) Working Standard Solutions: A series of working standards were prepared to investigate the linear 
range and limit of detection of the method developed. 40, 30, 20 and 10 ml of the stock OTC solution 
were pipetted into 100 mL volumetric flasks labeled 400, 300, 200 and 100 mg / L and made up to the 
mark with electrolyte. The 100 mg / L standard was diluted 1 in 2 sequentially to generate 50, 25, 12.5 
and 6.25 mg / L standards. Each working standard was injected three times.
Diagram 6.10 (a) Linear Range, (b) Calibration Curve
Result: Injections of concentrations above 200 mg / L OTC demonstrate no variance in peak height or 
area, Table (xi). This was taken to be the upper detection limit. Linearity was displayed between 
concentrations 12.5 mg / L and 200 mg / L. Average correlation coefficient was found to be 0.9994 with 
slope 0.055. No change in peak height / area was recorded below 6.25 mg / L, thus the limit of detection 
was taken to be 6.25 mg / L.
6.4.2 Repeatability
The repeatability of the method was examined by injecting ten samples of 200 mg / L OTC solutions 
from similar and different carousel vial positions to ascertain variability between injections.
Result: Standard Deviation and Relative Standard Deviation were calculated from peak height and 
found to be 0.28% and 2.62% respectively for injections from the same vial position and 0.32% and 
2.99% respectively for injections from different vial positions.
6.4.3 Precision and Accuracy
The precision and accuracy of the method was determined by conducting intra- and inter-assay 
variability tests. The intra-assay variability test consisted of analyzing five concentrations of each 
standard, 12.5 mg / L -  200 mg / L and injecting each standard six times in one batch. The amount of 
OTC in each standard was plotted against the average peak height to determine the correlation 
coefficient. Results from four different intra-assay variability tests, collected over four days were used 
to find the % coefficient of variation and % deviation.
Result: Over the concentration range studied the average RSD was found to be 2.82% and the average 
deviation was found to be 0.41%.
6.4.4 Recovery
The CE method developed was applied for the determination of oxytetracycline in a pharmaceutical 
product. Recoveries were calculated from an antibiotic tablet containing the following ingredients; 
Oxytetracylcine Dihydrate (250 mg), Lactose (17.66 mg), Starch Maize (21 mg), Povidone (10 mg), 
Sodium Lauryl Sulphate (3.33 mg), Stearic Acid (15.66 mg) and Sodium Starch Glycollate (15.66 mg). 
Recoveries were examined at 75%, 87.5%, 100%, 112.5% and 125% OTC Label Claim.
Stock Standard and Working Standard Solutions
A 2,512 mg / L stock OTC solution was prepared by weighing 0.2512g OTC dihydrate, dissolving in 
buffer, transferring to a 1 L volumetric flask and making up to the mark with electrolyte. To generate a 
series of working standard solutions containing 75% to 125% OTC, a series o f concentrations were
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prepared. 7.5, 8.75, 10, 11.25 and 12.5 ml o f the stock OTC solution were pipetted into 100 ml 
volumetric flasks labelled 75%, 87.5%, 100%, 112.5% and 125%. These standards solutions were made 
up to the mark with electrolyte.
(ii) Placebo Solutions
A placebo solution was prepared by weighing 0.01764g Lactose, 0.02123g Starch Maize, 0.0101 lg  
Povidone, 0.0033g Sodium Lauryl Sulphate, 0.0157g Stearic Acid and 0.0156g Sodium Starch 
Glycollate dissolving in electrolyte, transferring to a 1 L volumetric flask and making up to the mark 
with electrolyte. The placebo solution was placed in an Ultrasonic bath for 30 min to degas and filtered 
through a Gelman Acrodisc (0.45pm) filter.
(iii) Spiked Placebo Samples
Five placebo solutions were prepared by weighing an appropriate amount of each ingredient and placing 
in separate 100 ml beakers. To each of these was added 0.0187g, 0.0218g, 0.02512g, 0.0282g and 
0.03125g of OTC dihydrate. These solutions were dissolved in electrolyte and transferred to 1 L 
volumetric flask. The final volume was made up to the mark with electrolyte, placed in an Ultrasonic 
bath for 30 min to degas and filtered through a Gelman Acrodisc (0.45pm) filter.
The placebo was injected to see if there was any response at the migration time of the OTC analyte. 
Result: As no detector response was apparent, six injections o f each OTC standard and spiked placebo 
samples were made. % Recovery was calculated by comparing expected and found peak areas and peak 
heights.
Result: Peak area and height values are higher for spiked placebo sample than those obtained from 
injections of standard OTC solutions indicating that the method developed may not be appropriate for 
this pharmaceutical product, % Recovery = 107.94%. This result was thought to be very high and thus 
this procedure was not repeated therefore statistical analysis could not be carried out.
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6.4.5 Specificity
Each product ingredient was prepared ten times their concentration label claim to investigate the 
selectivity of the method developed.
Ingredient Preparations
0.01760g Lactose, 0.02133g Starch Maize, 0.0099g Povidone, 0.003 lg  Sodium Lauryl Sulphate, 
0.0162g Stearic Acid and 0.0158g Sodium Starch Glycollate were weighed, dissolved in electrolyte, 
transferred to separate 6 x 100 mL volumetric flask and made up to the mark with electrolyte. Each 
solution was degassed for 30 min and filtered as before. Each solution was injected using the same 
operating conditions as before.
Result: A large response appeared when 1000 mg / L povidone was injected at the same retention time 
as OTC.
6.4.5.1 Separation of OTC and PVP
(i) Electrolyte Preparation
10 mM SDS was weighed and added to 250 ml of the electrolyte solution. The solution was then
transferred to a 1 L volumetric flask and made up to the mark.
(ii) Capillary Conditioning As in Section 6,3.3
(iii) Standard Solutions
Three standard solutions containing 1000 mg / L PVP, 250 mg / L OTC and a mixture of both were 
prepared. O.OOlOg PVP was weighed, dissolved in electrolyte, transferred to a 100 mL volumetric flask 
and made up to the mark. 0.0025g OTC Dihydrate was weighed, dissolved in electrolyte, transferred to
a 100 mL volumetric flask and made up to the mark. O.OOlOg of PVP was weighed and added to
0.0026g OTC Dihydrate, dissolved in electrolyte, transferred to a 100 mL volumetric flask and made up 
to the mark. Injections of each solution were performed (n=3).
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Result: The migration of PVP was altered upon addition of the surfactant from approximately 5 min 
toapproximately 6 min whereas the OTG response remained unaffected. Recovery studies were then 
repeated with SDS in the electrolyte and final recovery was found to be 100.01%.
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CHAPTER SEVEN 
POVlbONE ANALYSIS
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Povidone was chosen as the next analyte as the CE method developed for OTC also generated responses 
for PVP. The aim of this study was to develop and validate a method for the determination of PVP so 
that the method could be employed for the simultaneous analysis of both OTC and PVP contained in the 
same product.
HO
Diagram 7.1 Povidone h  = - 5 0
Povidone, (poly(vinyl)pyrrolidone), (PVP), is a low molecular weight polymer (average molecular 
weight 100,000 to 400,000 atomic mass units (a.m.u.)). It is used in pharmaceutical products as a 
binding agent. Povidone contains both ionic and hydrophobic characteristics and may be sparingly 
soluble in aqueous solutions. This compound has been extensively used for a variety of functions both 
in CE and HPLC applications. Reports indicate that it is used as a sieving matrix, binding agent, 
viscosity builder, electroosmotic flow suppressor and complexating agent.
7.2 Literature Review
A literature search indicates that PVP has not been determined previously by capillary electrophoresis. 
It has been used in CE applications but no CE method has been validated for the determination of PVP 
itself. PVP is commonly added directly to the electrolyte in CE, or can be used to coat the inner 
capillary wall depending on the matrix and chemical structure of the compounds to be analysed. A CE 
technique111 for a single run determination of iodine and iodide in commercially available antiseptic 
such as povidone-iodine is reported. Tris-HCl electrolyte at pH 8.5 with direct UV detection at 214 nm
was used. Reponses due to povidone occurred at 4 min. The method was validated only for L and Y.
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7.1 Introduction
Povidone is used as a viscosity builder112 for an electrically conducting interface for a biomedical 
sensor. This paper discusses bioadhesive performance and demonstrates povidone’s suitability for its 
purpose. Oligonucleotides113 have been analysed by CE coupled with electrosrpay spectrometry in a 
PVP matrix. The coated fused silica capillary was filled with an aqueous solution of PVP that behaved 
as a pseudo-phase so that oligomers with hydrophobic modifications were retained longer than their 
unmodified analogs. PVP has also been used to influence the mobilities of diastereomeric derivatives of 
enantiomers separated by CZE114. PVP was added to a 30 mM phosphate electrolyte prior to pH 
adjustment and capillary equilibrated to ensure baseline stability. The spreading of mobility values by 
interaction with PVP was examined as a function of the electrolyte’s viscosity. PVP has also been used 
as a sieving matrix115 for the determination of DNA fragments by CE. The effects of PVP concentration 
and electric field strength on separation efficiency were examined. A selection of fragments were 
dissolved both in PVP and electrolyte and it was demonstrated that PVP improved separation efficiency 
better than electrolyte.
A qualitative PVP screening technique was devised by Trimpin et al.116 This technique involved 
examining PVP’s biodegradability by Matrix-Assisted Laser Desorption-Ionisation Time-Of- Flight 
Mass Spectrometry (MALDI-TOF-MS). Results indicate the degradation course of PVP. PVP has been 
used as an electroosmotic flow suppressor in the CGE117 determination of cyanine-labelled amino acid 
enantionmers modified with cyclodextrin. The separation of six amino acid enantiomers could be 
achieved by using a 1% PVP solution containing 70 mM y-cyclodextrin. It was also shown that PVP 
does not effect the selectivity of optical isomers.
PVP has been used as a complexating agent in the CZE118 separation of ten nitrophenols. PVP was 
present at a concentration of 2.5% (w/v) in the electrolyte. Nitrophenols were detected in the 20-80 ppb 
range. Another CEC119 method for determining chiral proteinogenic a-amino acids included PVP in the 
electrolyte to optimise separation between chemically similar compounds. PVP 0.5% (w/v) was added to
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a 20 mM sodium citrate buffer containing 9% 2-propanol and 1% tert.-butylmethyl ether. PVP 
concentration was optimised to enhance stereoselectivity of the structures analysed. PVP has been used 
to shield sepharose samples in order to prevent the matrices from binding foreign proteins in their 
analysis by HPLC.120
7.3 Method Development
7.3.1 Confirming PVP Response
Electrolyte: 10 mM Tris-HCl, 10 mM SDS, pH 7
Sample. 1000 mg / L PVP
Operating Conditions: As per Section 6.3.3
(i) Electrolyte Preparation
1.210g Tris and 10 mM SDS were weighed and dissolved in ultrapure water, transferred to a 1 L beaker 
containing approximately 900 ml ultrapure water and stirred with a glass rod. The electrolyte pH was 
adjusted to 7 upon addition of 1 M HC1 drop wise with a Pasteur pipette.
(ii) Stock Standard Solution
A standard solution of PVP was made by weighing 0.0099g of PVP solid, dissolving in electrolyte, 
transferring to a 100 ml volumetric flask and making up to the mark. Injections of 1000 mg/L were 
made, (n=3).
Result: An assymmetric response was observed at approximately 5 min.
Diagram 7.2 Initial PVP Response
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Due to the shape of peaks obtained from initial responses, it was decided to examine the effect of 
adding an organic solvent to see if peak shape could be improved. Organic solvents chosen were 
methanol and acetonitrile. These solvents are routinely used to improve peak shape in CE, as discussed 
earlier Section 5.2, Section 6.2.
7.3.2 Addition of Organic Solvent 
Electrolyte-Organic Solvent Preparation
25, 50 and 75 ml methanol and 25, 50 and 75 ml acetonitrile were added to 6 x 250 ml of electrolyte. 
These solutions corresponded to 10%, 20% and 30% organic solvent (v/v). Solutions were placed in an 
Ultrasonic bath and filtered as before. Three injections of 1000 mg / L PVP solution were made using 
each of the six electrolyte systems.
Result: Additions o f methanol resulted in slower migration times and poorer peak shape, however upon 
additions of acetonitrile, peak shapes were symmetric and migration times unchanged. Acetonitrile, 
10% (v/v) was added to the electrolyte for all future investigations.
i
>
Diagram 7.3 Symmetric PVP Peaks with ACN
7.3.3 Electrolyte pH Variation 
(i) Electrolyte Preparation:
1.210g Tris and 10 mM SDS were weighed and dissolved in ultrapure water. This solution was 
transferred to a 1 L beaker containing approximately 900 ml ultrapure water and stirred with a glass rod.
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Acetonitrile (25 ml) was added to 250 ml of electrolyte. Electrolyte pH was adjusted to 3, pH 5 and pH 
10 upon addition of 2 M HC1 drop wise with a Pasteur pipette.
Result: No response was observed using these conditions.
Subsequent injections of electrolyte and sample using the same conditions were made however no 
response was obtained. This result would suggest that conditions inside the capillary have changed. Due 
to the analytes polymeric nature, it is possible that sample may have adsorbed onto the capillary wall. In 
order to try to remove sample from inside the capillary, the capillary was washed sequentially with 
isopropanol for 30 min, ultrapure water for 30 min, 1 M NaOH for 20 min and ultrapure water for 30 
min followed with electrolyte for 30 min.
Three injections of electrolyte alone were performed to ensure all sample had been removed.
Result: No response was observed at the migration time of the sample thus this was thought to confirm 
adhesion of the analyte onto the capillary wall.
A new capillary was created using the previous method however it was necessary to coat the inside of 
the capillary wall with a suitable wall modifier to ensure that sample would travel unhindered through 
the capillary.
7.3.4 Capillary Wall Modification
Cetyl Trimethyl Ammonium Bromide (CTAB) is a cationic surfactant previously reported in capillary 
wall modification26'29.
Electrolyte Preparation: As in Section 7.3.1
0.109g CTAB was added to previously prepared electrolyte solution and made up to the mark. To 250 
ml of electrolyte was added 25 ml acetonitrile. The pH was adjusted to 7 upon addition of 1 M HC1 drop 
wise with a Pasteur pipette. Electrolyte was placed in an Ultrasonic bath for 30 min and filtered as 
before.
Injections of 1000 mg / L PVP in electrolyte were made,
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Result: No response was observed upon injection of PVP standard and it was thought that the EOF was 
reversed.
Another capillary was created using the previous method and electrolyte in order to regenerate PVP 
response. Injections of 1000 mg / L PVP in electrolyte were made, n = 3.
Result: Symmetric responses were observed at approximately 5 min.
A range of PVP concentrations were prepared in order to (a) establish whether sample adsorption is 
independent of amount injected.
7.3.5 Investigating Linearity
Working Standards: A 300 mg / L standard concentration was prepared by weighing 0.0030g of PVP 
solid, dissolving in electrolyte, transferring to a 100 mL volumetric flask and making up to the mark.
This standard solution was diluted sequentially with 1 in 2 and 1 in 10 dilutions to generate a series of 
standards containing total PVP concentrations of 300 mg / L, 150 mg / L, 75 mg / L, 30 mg / L, 15 mg / 
L and 3 mg / L. Each standard was injected three times.
Result: A linear response was obtained over the concentration range studied.
Diagram 7.4 Peaks Increasing Linearly with Concentration PVP 
7 3.5.1 Limit of Detection
(i) Working Standards
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A series o f standards were prepared by pipetting 1, 2, 3, 4, 5, 10, 20 and 30 ml of the stock solution and 
transferring to separate 100 ml volumetric flasks. Each working standard was made up to the mark with 
electrolyte and injected onto the CE system. Each standard was injected three times.
Result: Linear responses were not observed as peak shape was dramatically altered and peak area or 
peak height values obtained were not consistent.
When injections were repeated, any response due to sample was not detected.
Another capillary was created as the previous capillary was thought to be irreversibly effected by 
sample adhesion. When the initial response due to PVP was made during validation of OTC method, 
product ingredients such as lactose and starch maize were injected prior to PVP. A similar capillary 
environment was created in an attempt to establish whether these ingredients had coated the capillary.
7.3.6 Effect o f Products Ingredients
The creation of a new capillary and subsequent injections of product ingredients at similar concentration 
as before were performed. Each ingredient was injected six times followed by injections of PVP (n=3). 
It was thought that the presence of sample ingredients Lactose, OTC and Starch Maize had in some way 
modified the capillary wall that provided good PVP peak symmetry. When these injections were 
performed as before however, peak height and area values together with peak shape and migration time 
did not improve.
7.3.7 Electroosmotic Mobility:
The heof was determined upon injection of 2 mM 2-Naphthol (0.288g in Methanol) and was found to 
have a migration time at 6 min which is close to the migration time of the compound.
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CHAPTER EIGHT 
DISCUSSION
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8.1 Benzoic Acid Analysis
Direct UV detection was used for the analysis o f this compound as it intrinsically absorbs UV light at 
215 nm. Analysis time at 5 min compares favourably with methods reported in the literature, Section 
3.2. The calibration graph obtained demonstrated that the detector responded according to variations in 
concentration of analyte. Familiarisation with the CE instrument was established.
8.2 Inorganic Cation Analysis
Indirect photometric detection at 215 nm was used for the analysis of inorganic cations employing three 
different electrolyte systems. As tromethamine acquires a positive charge at pH 4.8, it was thought that 
it would be detected as a cation with similar electrophretic behaviour as the ammonium cation reported 
in the literature73'85. Electropherograms using the copper sulphate and phosphate electrolytes displayed 
responses at the migration time of Na+ ion, 2.5 min. Following injections of ultra-pure water only, these 
responses remained. As all standard solutions were prepared with ultra-pure water, it was thought that 
there was a higher concentration of sodium in the water than expected. IC analysis however 
demonstrated that the concentration of sodium was acceptable. Non-linear behaviour was also noted 
using the phosphate electrolyte. This was possibly due to the build up of sodium residues on the 
capillary wall. Upon creation of a new capillary and application of the third electrolyte system, DDP, 
linear responses were obtained, free from interference. This electrolyte was deemed best for the analysis 
of tromethamine. The ammonium ion was detected at less than 5 min.
8.3 T romethamine Analysis
8.3.1 Selection of Detection System
As tromethamine has no intrinsic UV response, indirect UV detection was necessary for the 
determination of the analyte within the CZE system. Indirect UV detection has been used previously for 
the detection of small inorganic cations. There are two methods of approach using this detection system. 
The first is to derivatise the compound into a form that allows direct UV detection. As these procedures
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are laborious and often non-specific the most convenient method is to add a UV absorber to the 
electrolyte and thus facilitate the indirect detection of the compound in the CE system. A UV absorber 
in the buffer will generate a high background absorbance and as the analyte passes the detector, a 
proportional amount of the UV absorber will be displaced and cause a dip in the background 
absorbance. The main consideration in the choice of UV absorber was to match its mobility with 
tromethamine.
8.3.2 Choosing a Suitable Electrolyte
(i) Copper Sulphate Electrolyte: The first buffer system chosen for initial determination of 
tromethamine was a Copper (II) Sulphate-18-Crown-6-Ether-Formic Acid buffer because it has been 
used previously for the analysis of cations, Section 4.2. Results from inorganic cation analysis exhibited 
a response for the ammonium cation at 5 min. The pH of the buffer was adjusted to 5 with formic acid 
as this is one unit above the pKa of the analyte. The addition of 18-Crown-6-Ether was chosen as the 
UV absorbing species and using indirect detection with reversed polarity injections of the non-UV 
absorbing analyte generated a response at approximately 5 min. Gravity injection was chosen as this is 
reported to be the simplest injection form and the amount injected does not depend on the 
electrophoretic mobility which was considered appropriate for the initial determination of the analyte. 
All electropherograms obtained showed responses at 2.5, 3, 3,5, and 10 min as well as the response at 5 
min due to sample. No attempt was made at this stage to determine the identity of these peaks as it was 
more convenient to choose a more suitable electrolyte.
(ii) Imidazole Electrolyte: The second buffer system was chosen on the basis that imidazole would act 
as the UV absorber and has been previously reported for inorganic cation analysis. Both imidazole and 
tromethamine are structurally similar as they both form ammonium ions at low pH. Results show 
responses at 5 min however, peak splitting is observed. Differences in degree of peak split are observed 
upon injecting different concentrations of analyte. The general trend follows that on increasing
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concentration, the calculated peak height ratio decreases, within the response observed. From 
electropherograms obtained at higher concentrations, the second peak appears as a shoulder instead of 
an individual peak as seen with lower concentrations. It was thought that the ionisation of the 
component was different to that observed using copper sulphate. The pH of the electrolyte could have 
been altered to determine the optimum pH in order improve peak shape.
As peak symmetry was acceptable using copper sulphate electrolyte, it was thought that the presence of 
18-Crown-6-Ether was in some way responsible for the modification of the capillary wall. Addition of 
the inclusion complexating agent at the same concentration as the copper sulphate electrolyte however 
did not improve peak shape. All electropherograms obtained showed responses at 2.5, 3, 3.5, and 10 
min as well as the response at 5 min due to sample.
8.3.3 Identification of Unknown Peaks
When injections of tromethamine, ultra pure water and electrolyte were performed using both copper 
sulphate and imidazole electrolytes, peaks consistently appeared with average migration times at 2.40, 
2.96, 3.48 and 9.13 min, (n=10). It was necessary to establish the nature of these responses before 
another buffer system was chosen. As both electrolytes have been successfully used for the analysis of 
cations previously, and as standard tromethamine solutions were prepared with ultra pure water (copper 
sulphate) and with buffer as solvent (imidazole) it was considered the presence of these responses were 
possibly due to cations in water. Cation standards were injected into the CE system using imidazole as 
electrolyte and identified as K+, (2.4 min), Ca2+ (2.96 min) and N a1 (3.48 min). A neutral marker, 2- 
naphthol, was introduced into the system and migrated at approximately 10 min therefore the 
unidentified peak at 9 .13 min was thought to be due to the movement of the bulk electrolyte.
8.3.4 DDP Electrolyte
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This electrolyte was the most successful for analyzing inorganic cations as interferences previously 
found were now absent from all electropherograms and detector showed sharp symmetrical responses. 
Responses due to tromethamine at approximately 5 min were also acceptable for these reasons.
8.3.5 Electrolyte Composition
Because DDP functions as a UV absorber, it was decided to investigate the role of the organic additive 
18-Crown-6-Ether in the buffer system. Unlike the copper sulphate and imidazole electrolytes, on 
injection of sample, electrolyte or standard, no other peaks appeared other than that due to 
tromethamine. The DDP buffer was prepared without crown ether and injections of sample made. It was 
found that no difference in retention time was seen and that the capillary wall was not altered by the 
presence / absence of the additive. It was decided to omit the addition of crown ether to the electrolyte 
in subsequent investigations.
8.3.6 Effect of Electrolyte pH
The degree of ionisation of a species present in the electrolyte system depends on the pH of the solution. 
By altering the pH of the DDP buffer with a-hydroxyisobutyric acid, the flow rate (EOF) inside the 
capillary was controlled. Low buffer pH values were thought to enhance the protonation of the 
monoacidic amine giving it an overall positive charge however as tromethamine contains a weakly 
ioni sable group it was expected to be charged within a narrow range above or below its pKa value. The 
pKa value is 4.8 and results demonstrate that it is charged within pH 3.5 -  6.5. The EOF was apparent in 
the range pH 4.5 -  11. Optimum mobility was observed at pH 5.2.
8.3.7 Effect of Voltage Variation
Voltage variation affects the electrophoretic and electroosmotic mobilities in the CE separation. This 
results in altering the conducting medium in the capillary in terms of changing current, temperature 
inside the capillary. In order to determine the optimum operating voltage for the electrophoretic 
separation, variation of this control mode was achieved in the mid-voltage range from 15 kV to 25 kV
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in increments of one. Changes in voltage can affect Joule Heat generation and thus a capillary cooling 
jacket was applied during all voltage variations. Due to the use of ambient temperature conditions, the 
generation of any Joule Heat was thought to be adequately dissipated as there was no significant change 
in peak symmetry and thus the analyte was thought to be chemically stable under conditions of 
increasing voltage. Analysis time was reduced from 5 min to 3 min using an optimum voltage of 20 kV 
chosen from an Ohm’s Law Plot.
8.3.8 Effect o f Temperature Variation
Direct automated control of capillary temperature was not an option using the Dionex CES 1 Model. 
Electrophoretic mobility is best at close to mid-day laboratory temperatures, approximately 17°C Fig
31. There is no evidence to suggest that the structural nature of the sample or the injection volume was 
in any way altered with changing temperatures as peak response was maintained. As temperature 
changes usually affect buffer viscosity, these measurements could have also been taken.
8.3.9 Effect o f Ionic Strength Variation
Ionic strength of the electrolyte has significant effects on solute mobilities and separation efficiency. To 
determine the effect of altering ionic strength of the DDP electrolyte, concentrations in the range 0.312 
-  5 mM were examined. As the temperature was not controlled, the EOF increased with ionic strength, 
as expected. It was also expected that the migration time of the analyte would increase with increasing 
ionic strength, by increasing the ionic strength, the migration time decreases by approximately 2 min in 
the range examined. Concentrations above 5 mM could not be examined as the instrument automatically 
shut down due to excessive heat inside the capillary. As this instrument did not have a temperature 
control system, it was impossible to further examine effects o f increasing ionic strength.
103
The method developed was validated in accordance with ICH3m . The parameters for method validation 
include linear range, linearity, limit of detection, repeatability, precision, accuracy, specificity and 
recovery
8.3.10 Linearity, Linear Range and Limit of Detection
The linear range of the method was investigated from 1-50 mg / L which accommodates the required 
80-120% of the test concentration (12 mg / ml). A wide concentration range was investigated to 
determine at which concentrations the method deviated from linearity. From table (vi), it can be 
observed that concentration below 2.5 mg / L and above 25 mg / L deviated from linearity. The linearity 
of the method was examined in the range 5 mg / L to 25 mg / L, n = 6. Calibration curves compiled 
gave a correlation coefficient 0.9992 ± 0.029 with an intercept o f -2.9 x 10'2 ± 0.017 and slope 0.098. 
The sensitivity of the system was found to be 0.98 absorbance units / m g 1. The lowest operating limit of 
detection was found to be 2.5 mg / L, as responses below this concentration remained relatively constant 
and thus independent of changing concentrations.
8.3.11 Repeatability
System repeatability was assessed in terms of run to run variation between responses obtained from 
similar and different vial positions by the same operator. In order to examine the repeatability of the 
method ten successive injections of 10 mg / L standard from the same vial position were carried out. 
Standard deviation and relative standard deviation values were calculated for peak height and found to 
be 0.14 and 2.01%, respectively. Variations between injections collected from samples located in 
different vial positions displayed standard deviation values calculated by peak height data was found to 
be 0.360 with an relative standard deviation o f 3.43 %.
8.3.12 Precision and Accuracy
The precision and accuracy of the method was determined by conducting intra- and inter-assay 
variability tests. Concentrations in the range 5 to 25 mg / L were prepared over a series of four days and
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analysed. Variations within and between days were calculated at n = 6. Standard deviation and relative 
standard deviation results were calculated form peak height data in order to examine the co-efficient of 
variation of the method developed. Average RSD was found to be 0.42% and the average deviation was 
found to be 1.62%. The average deviation is inflated owing to the relatively poor deviation obtained for 
the concentration of 5 mg / L. The remaining four concentrations gave an average of 0.94%.
8.3.13 Specificity
The method developed was applied to a commercial eye-care product containing tromethamine at 12 mg 
/ ml in order to assess the specificity of the method. Injections of a placebo solution containing other 
product ingredients did not generate detector response at the retention time of tromethamine. The 
selectivity of this method could further be tested if the method was applied to a matrix containing 
tromethamine and its synthetic precursors, degradation products or excipients. A small peak was 
observed at 1.91 min in all electropherograms and was thought to be due to sodium residues remaining 
from capillary conditioning. This response did not interfere with the response due to analyte.
8.3.14 Recovery
Recovery was calculated from injecting spiked placebo and standard solutions and comparing the peak 
heights obtained. Initial recovery studies were low at approximately 98% and it was thought that the 
viscosity of the sample solution had in some way affected the inner capillary wall. Standard solutions, 
prepared with ultrapure water and in sample matrix, were tested with a viscometer however no 
significant variations in measurements were observed. Mean recovery was found to be 102.98 ± 2.59%
8.4 Oxytetracycline Analysis
8.4.1 Choice of CE Technique
Capillary Zone Electrophoresis was the method of choice for initial determination of the analyte in the 
pharmaceutical matrix. It was thought that on considering the structure of OTC which consists of a
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tricarbonyl system attached to polar constituents, electrophoretic mobility would readily be achieved on 
the basis of charge:mass ratio.
8.4.2 Selection of Detection System
Direct UV detection was an obvious method of choice for this compound. A UV scan of various 
concentrations o f OTC in methanol yielded a maximum wavelength at 270 nm. Previous CE methods 
have reported using a wavelength of 254 nm. For initial investigations, this was the wavelength chosen. 
A Beer-Lambert Plot was constructed which displayed linearity up to concentrations of 60 mM.
8.4.3 Choice of Suitable Electrolyte
Due to availability o f tromethamine (Tris), and its prevalent use as an aqueous electrolyte in both CZE 
and MECC, it was therefore decided to examine its suitability as the buffer for initial determination of 
OTC response. Tris electrolytes are alkaline electrolytes at pH 10.4. However, it was decided to lower 
buffer pH to ensure OTC was charged in the capillary. Due to OTC instability in strongly alkaline 
media and degradation in highly acidic solutions it was decided to reduce the pH of the electrolyte to 
neutral. Tris has no UV absorbing properties due to its chemical structure, as has already been 
discussed, and thus it was considered that there would be no interference from the background 
electrolyte during analysis. Oxytetracycline was found to be soluble in this electrolyte system that 
further enhanced the choice of electrolyte.
Upon application of the Tris-HCl electrolyte at pH 7, initial response due to OTC was noted at 
approximately 5 min. Peak efficiency and peak shape were poor.
8.4.4 Electroosmotic Flow
Injection of 2-naphthol (5mM) onto the system gave an indication of the migration of the bulk 
electrolyte. The migration of the EOF at 3 min was close to the analyte migration at 5 min. Suppression 
of the electroosmotic flow has been reported using various methods however, it was decided to examine 
the effect of varying EOF dependent factors before a decision was made to supress the EOF.
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8.4.5 Peak Efficiency
CE is reputed for lack of sensitivity primarily because of the length of the detector cell window, as A = 
s e t .  Thus, from the Beer-Lambert Law, the absorbance is directly related to the cell path length. The 
fused silica capillaries used in this report consist of a cell path length of 0.5 cm. The larger the cell path 
length value, the lower the concentration of analyte detected. Poor peak efficiency and low detector 
response were observed in initial investigations. When the operating wavelength was changed from 254 
nm to 210 nm in an attempt to enhance detector response, a decrease in electrophoretic migration inside 
the capillary was observed. When wavelengths above 254 nm were used, no detector response was 
observed. The operating wavelength was maintained at 254 nm.
Detector response is proportional to the amount of sample loaded onto the capillary and therefore this 
response dependent parameter was investigated subsequently. Injection volume was doubled by 
changing program conditions and increasing the sample load from 0.814 nl to 1.704 nl by injecting for a 
further 10 sec. Detector response generated peak heights double the value of original heights for the 200 
mg / L standard. Changing the sample solvent from methanol to electrolyte resulted in producing sharp, 
symmetric peaks.
The selection of 1 M HC1 and 0.1 M HC1 as sample solvent caused poor peak shapes probably due to 
acid degradation of OTC. This could have been confirmed by injecting EOTC standards.
8.4.6 Electrolyte Composition
The pharmaceutical matrix selected to validate this method was known to contain non-aqueous 
ingredients. Organic solvents were added to the electrolyte in the hope that they would improve the 
solubility of other product ingredients in the buffer. Organic solvents are routinely used to alter the 
mobility of one analyte to improve resolution or enhance selectivity. Methanol was added to electrolyte 
systems in other OTC methods as discussed earlier thus, the impact of methanol addition upon 
electrophoretic and electroosmotic behaviour was investigated in this method. Organic solvent addition
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can also alter electroosmotic flow depending on the type and quantity o f solvent used. Other system 
effects include viscosity, dielectric constant and zeta potential.
8.4.6.1 Effect o f Methanol Addition
The effect of adding methanol to the aqueous electrolyte was established in terms of monitoring both 
electroosmotic and electrophoretic mobilities. OTC migration was reduced by approximately 7 min and 
the migration of the EOF reduced by approximately 5 min with 40% (v/v) methanol, Fig 42. 
Electrophoretic and electroosmotic speed was hindered upon addition of the methanol as expected.
8.4.6 2 Effect of SDS Addition
Addition of surfactants to electrolyte systems for OTC and tetracycline analysis in other MECC 
applications have been reported and thus the effect of adding SDS to the tris buffer was examined. SDS 
has a CMC value of 8.27 mM. No advantage was offered for analysis of OTC in this electrophoretic 
analysis at this stage of development. SDS addition caused electrophoretic and electroosmotic mobility 
reduction.
8.4.7 Effect of Electrolyte pH
As the pH increases electroosmotic flow increases as the charge on the inner capillary wall increased. 
The degree of ionisation of OTC is also altered by increasing pH of the buffer, as its speed through the 
capilliary is increased by approximately 3 min over the pH range examined. Initial Buffer pH variations 
involved selecting a 200 mg / L standard OTC solution and injecting at various pH values at n = 3. 
Electrolyte pH values from pH 7 to pH 3 were also carried out however, peak shape deteriorated 
possibly due to analyte degradation. At extreme acidic conditions, peak splitting was obvious and the 
response due to OTC was no longer apparent. These results demonstrate that the electrophoretic 
mobility of this anion increased as it passed through the capillary unhindered, as the pH of the buffer 
increased, as was expected.
8.4.8 Effect of Voltage Variation
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Mid-range voltages (15 - 25 kV) were examined by programming the instrument accordingly. 
Electrophoretic and electroosmotic mobilities were monitored as a function of varied applied voltage. 
Application of a cooling jacket above 20 kV was essential during operation as high applied voltages 
caused increased currents which resulted in Joule heating in the capillary. The current produced did not 
exceed 60 pA. It is evident that altering the applied voltage affected both electrophoretic and 
electroosmotic mobility. Results obtained follow those expected as higher voltages reduced analysis 
times. Electrophoretic mobility is affected to a greater extent than the electroosmotic mobility as the 
analysis time is reduced by over 5 min as the applied voltage is increased from 15-25 kV. Change in the 
migration of the neutral species was substantially less and amounted to less than 3.5 min over the 
applied voltage range.
8.4.9 Effect of Temperature Variation
The effect of varying temperature was not carried out during this procedure as inconclusive evidence 
was obtained from results displayed compared to the analysis o f tromethamine. Temperature 
fluctuations inside the hood of the instrument could not be accurately followed upon application of a 
thermometer only. Results obtained could not be directly correlated with laboratory humidity. It may 
therefore be necessary to monitor smaller fluctuations both outside and inside the instrument and over 
longer periods of time to truly appreciate and understand the effect of laboratory temperature on analyte 
mobility through the capillary, if any.
8.4.10 Effect of Ionic Strength Variation
Ionic strength of the electrolyte is related to the viscosity of the electrophoretic and electroosmotic 
mobility. The concentration of electrolyte was varied from 10 mM to 100 mM. Ionic strengths greater 
than 70 mM caused a build up of current. The highest current recorded was 71 pA. The CE system 
usually shuts down when currents between 60 to 70 pA are produced. Above 50 mM tris, the 
electroosmotic flow remains almost unaffected by the change in electrolyte concentration. The
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electrophoretic mobility of OTC reduces as ionic strength increases by approximately 2 min on 
increasing from 10 to 70 mM. The fastest rate of analyte mobility was seen at tris concentration of 70 
mM however electrolyte concentration of 50 mM was deemed best for future procedures.
8 .4.11 Linearity, Linear Range and Limit of Detection
The linear range of the method was investigated from 6.25 - 400 mg / L which accommodates the 
required 80-120% of the test concentration (250 mg / ml). A wide concentration range was investigated 
to determine at which concentrations the method deviated from linearity. Concentrations below 6 mg / L 
and above 200 mg / L deviated from linearity. The linearity of the method was examined in the range
12.5 mg / L to 200 mg / L, n = 6. Calibration curves compiled gave a correlation coefficient 0.9994 with 
an intercept of 1.7 x 10'2 and slope 0.055. The sensitivity of the system was found to be 0.55 absorbance 
units / mg'1. The lowest operating limit of detection was found to be 6 mg / L, as responses below this 
concentration remained relatively constant and thus independent of changing concentrations.
8.4.12 Repeatability
System repeatability was assessed in terms of run to run variation between responses obtained from 
similar and different vial positions by the same operator. In order to examine the repeatability of the 
method ten successive injections of 200 mg / L standard from the same vial position were carried out. 
Standard deviation and relative standard deviation values were calculated for peak height and found to 
be 0.28 and 2.62%, respectively. Variations between injections collected from samples located in 
different vial positions displayed standard deviation values calculated by peak height data was found to 
be 0.32 with an relative standard deviation of 2.99 %.
8.4.13 Precision and Accuracy
The precision and accuracy of the method was determined by conducting intra- and inter-assay 
variability tests. Concentrations in the range 12.5 mg / L to 200 mg / L OTC were prepared over a series 
of four days and analysed. Variations within and between days were calculated at n = 6. Standard
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deviation and relative standard deviation results were calculated form peak height data in order to 
examine the co-efficient of variation of the method developed. Average RSD was found to be 0.415% 
and the average deviation was found to be 2.82%.
8.4.14 Recovery
The method developed was applied to an antibiotic tablet containing oxytetracycline at a label claim of 
250 mg (7w). Injections o f standard solutions (75-125% label claim), placebo solutions containing each 
product ingredient (concentration label claim) and spiked placebo solutions containing 75-125% label 
claim of OTC were made. No response was observed at the migration time of OTC. Recovery was 
calculated to be 107.94%.
8.4.15 Specificity
In order to assess the specificity of the method injections of a placebo solution containing other product 
ingredients at ten times their label claim were performed. A large response appeared at the same 
migration time of OTC. This response was due to povidone (1000 mg (w/w)). Upon addition of 10 mM 
SDS the PVP response slowed to 5 min thus allowing the recovery studies to be repeated. Final % 
recovery was calculated to be 100.01%. As ICH3 guidelines stipulate the method should be selective for 
the analyte to be examined in ten times the concentration of each other ingredient found in the product, 
the method was deemed specific for the analysis o f OTC in this product.
8.5 Povidone Analysis
8.5.1 Choice of CE Technique
Highly ionisable groups in PVP suggest that the analyte will undergo electrophoretic mobility within the 
capillary. Capillary Gel Electrophoresis would seem to be the most appropriate CE technique as solutes 
are separated due to size as analytes migrate through the pores of a gel filled capillary. Polymers with 
similar monomer units but differing chain lengths can thus separate on the basis of molecular sieving as 
they migrate with constant but different velocities. During the CZE analysis o f oxytetracycline using an
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aqueous buffer and ftised silica capillary however, a response was observed for PVP. The technique had 
to be adequately modified to facilitate unhindered mobility of the analyte through the bare capillary by 
choice of a suitable capillary wall additive.
8.5.2 Selection of Detection System
PVP is strongly UV absorbing confirmed by the presence of conjugated double bonds. UV absorbance 
at 210 nm generated weak asymmetric signals at 8 min. A UV scan of PVP showed multiple UV 
absorbance thus it was decided to remain using 210 nm. By programming the instrument to detect over 
a series of wavelengths, reponses due to analyte could have been improved with regard to peak shape 
and height / area obtained. Using this wavelength however, responses were obtained for concentrations 
as low as 3 mg / L PVP, which is comparable to limit of detections obtained for both tromethamine (2.5 
mg / L) and oxytetracycline (6.25 mg / L).
8.5.3 Choice of Suitable Electrolyte
Tris-HCl buffer was adequate for the determination of the analyte in the matrix concerned. The addition 
of SDS has already been demonstrated upon separation of OTC and PVP during selectivity studies to 
alter the electrophoretic mobility of the compound significantly but at the expense of peak efficiency. 
No real advantage has been observed with addition of SDS. Injections could have been performed 
without SDS to examine whether the analysis time could have been reduced from 5 min. Other 
commonly used electrolytes e.g. phosphate, borate, acetate at pH 7 could also have been employed to 
estimate the best electrolyte for this determination. Other electrolyte systems have not been attempted 
for the analysis of the analyte due to solute interaction with the capillary wall. Aqueous or non-aqueous 
electrolyte systems must be modified with the selection of a suitable additive to facilitate reproducibility 
from run to run and also to ensure that the analyte does not undergo chemical modification inside the 
capillary. Initial determination of PVP response that displayed linearity could not be repeated upon
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further injections even though separation conditions were not altered. This was thought to be due to 
solute adhesion onto the capillary wall.
8.5.4 Electroosmotic Flow
The flow of neutral solutes in the capillary was achieved upon injections of 2-naphthol to examine the 
electroosmotic mobility in the capillary but in addition to assess the alteration of the environment on the 
capillary wall. Injections were performed on damaged and newly created capillaries before and after 
repeated injections of PVP. Results indicate however that no significant effect had occurred as the 
migration of the neutral species had not been altered. It is evident that the analyte has experienced 
chemical degradation due to declining peak symmetry and detector response even though 
electrophoretic migration did not appreciably change.
8.5.5 Organic Solvent Addition
The effect of organic solvent addition to the electrolyte system was necessary to improve peak 
symmetry. Methanol was added from 10-40% (v/v) but displayed no meaningful benefit. The addition of 
acetonitrile, 10-40% (v/v), on the other hand greatly improved peak shape. Acetonitrile at 10% (v/v) was 
therefore added to the buffer for subsequent analysis.
8.5.6 Electrolyte pH Variation
Using a low buffer pH the internal capillary wall is further protected with a layer of H+ ions that prevent 
analyte-wall interaction. As the pH of the electrolyte was lowered to 3, no response was observed for 
PVP injections, It may be assumed that the analyte is uncharged at low pH. Higher pH values were 
examined thereafter however similar results were seen, thus electrolyte pH is thus limited to near neutral 
conditions using this system.
8.5.7 Capillary Wall Modification
Many additives have been incorporated into buffer systems in CE to enhance analyte mobility through 
narrow bore capillaries. These additives provide wall coatings that prevent interaction between the
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solute and capillary wall. Wall coatings affect electroosmotic flow and electrophoretic mobility to 
different degrees depending on the additive chosen. Alteration of the zeta potential and shielding of 
ionised silanol groups is necessary in this application. When a cationic surfactant is added to an 
electrolyte system at a concentration below its CMC, a monolayer of positive charges forms on the 
capillary wall. CTAB was added at a concentration of 1.5 mM that is below its CMC but injections of 
the analyte demonstrated that the electroosmotic flow had been altered as EOF reversal was evident as 
the direction and rate o f electroosmotic flow depend on the polarity and magnitude of the zeta potential.
8.5.8 Effect of Products Ingredients
In order to establish the same conditions when PVP responses were repeatable, it was necessary to 
create the same electrophoretic environment. The creation of a new capillary and subsequent injections 
of product ingredients at similar concentration as before were performed. Each ingredient was injected 
six times followed by injections of PVP (n=3). It was thought that the presence of sample ingredients 
Lactose, OTC and Starch Maize had in some way modified the capillary wall that provided multiple, 
successive responses for PVP. When these injections were performed as before however, peak height 
and area values together with peak shape and migration time did not improve. Upon further injections of 
product ingredients, responses due to analyte were not obtained.
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CHAPTER NINE 
CONCLUSION
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9.2 Benefits of this Study
The methods developed and validated in this work are beneficial to the pharmaceutical industry as they 
present rapid, precise, cost effective alternatives to conventional analytical techniques currently used to 
analyse these compounds.
The tromethamine method is free from interference, specific, has low limits of detection and good 
recovery, it does not use organic solvents and has an analysis time of 3 min. Previously reported 
methods suffer from interference and require derivatisation and solid phase extraction steps prior to 
injection. This method could be employed as a routine analytical technique for the determination of 
tromethamine in a variety of pharmaceutical products.
The method for determining OTC is faster and has a better recovery than any of the methods reported in 
the literature. It has low limits o f detection and is accurate and precise. The method does not require 
extensive pre-injection steps and does not use organic solvents. This method could be employed as a 
routine analytical technique for the determination of oxytetracycline in a variety o f pharmaceutical 
products.
The method for determining PVP provides a basis for evaluation by CE as there are currently no 
methods reported in the literature for this determination.
9.3 Future Investigations
The method developed for tromethamine could be applied to a variety of pharmaceutical products and 
thus contribute to the existing body of knowledge for determining this compound. As many 
commercially available OTC containing products also contain impurities, further work in this area could 
involve its determination by this method from a mixture o f it’s degradation products.
The method for determining PVP would benefit from the application of a suitable wall additive so that 
the analyte would travel freely through the capillary. The method could then further be developed and 
validated in accordance with ICH3 guidelines.
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APPENDICES
Table (i) Changing Electrolyte pH for Tromafhamine Analysis
Volume of acid 
added (ml) pH
Concentration
tromethamme 
(mg / L)
Tromethamine 
migration (min)
EOF migration 
(min)
25.8 3.070 20 - -
7.86 3.560 20 5.79 -
5.36 3.780 20 c n o J.JJ -
3.86 4.150 20 4.88 -
3.56 4.650 20 4.58 10.85
3.11 5.203 20 4.00 10.39
3.86 5.500 20 3.84 8.50
2.65 5.735 20 3.51 6.05
2.43 6.067 20 3.15 5.93
2.41 6.505 20 2.99 5.31
2.40 7.072 a r\zu - 4.73
1.65 8.226 20 - 4.55
1.60 9.807 20 - 3.96
1.25 11.006 20 - o nnJ.5U
Table (ii) Electrosmotic/Electrophoretic Mobility as a Function of Electrolyte pH
PH tm (min) tnra (min) VEP Pep
(cffl“Y 'V  x 10’ )
A ZkU'T.U-'W 4.58 10.85 6.245 15.612
5.203 4.00 10.39 7.611 19.027
5.500 3.84 8.50 6.977 17.442
5.735 3.51 6.05 5.921 14.802
6.067 3.15 5.93 7.367 18.417
6.505 2.99 5.31 7.233 18.082
Table (iii) Altering Voltage for Tromethamine Analysis
Voltage
(kV)
Migration 
Analyte (min)
Migration 
EOF (min)
Current
f,uA)
Temperature
(°C)
Power
(fflW)
15 3.83 5.84 2 18.7 20
16 3.62 5.54 2 18.9 22
17 3.42 5.25 nJ 19.0 24
18 3.25 5.01 nJ 19.3 28
19 3.10 a n o  H ,  / O nJ 19.5 3o
20 2.96 4.59 3 20.0 40
21 2.72 4.17 3 20.3 41
22 2.58 " 3.96 oJ 20.5 42
23 2.41 3.75 nJ . 20.7 46
24 2.28 3.57 n 21.0 51
25 3.41 4 21.3 54
'able (iv) Altering Temperature for Tromethamine Analysis
Temperature (°C) Migration Analyte 
(min)
Peak Area (x 106) Peak Height (cm'1)
15.1 4.21 1.534 in nsX  X/ -  .V
16.3 3.86 1.610 10.10
17.2 3.00 1.527 10.00
18.5 3.14 1.401 10.20
19.4 3.58 1.498 10.15
20.5 4.19 1.550 10.05
21.4 4.01 1.670 10.10
22.6 3.98 1.590 10.10
23.5 3.82 1.611 10.05
Table (v) Altering Ionic Strength for Tromethamine Analysis
Concentration of 
DDPI Electrolyte 
(mM)
Analyte Migration 
(min)
EOF Migration 
(min)
Current
(pA)
5 2.98 5.30 '*>J
2.5 3.15 6.72 2
1.25 3.80 7.08 2
0.625 4.20 9.23 1
0.312 4.90 10.09 1
Table (vi) Linearity Studies for Tromethamine Analysis
Concentration of 
tromethamine 
(mg / L)
Migration time 
(min)
Average Peak 
Area (x 106)
Average Peak 
Height (cm'1)
0.315 3.23 0.086 0.51
0.625 3.30 0.106 0.58
1.25 3.23 0.170 0.50
2.5 3.27 0.427 2.10
5 3.29 0.492 3.98
10 3.30 0.918 5.95
15 n n n J J J 1.588 8.10
20 3.16 2.200 9.95
25 3.13 2.848 12.00
30 3.11 3.387 11.90
35 3.09 3.648 12.00
Concentration 
(mg / L)
N Correlation
Coefficient
Intercept Slope
5-25 6 0.9993 -2.63 x 10'2 0.0959
5-25 6 0.9992 -4.04 x 10'2 0.1013
5-25 6 0.9998 -2.07 x 1U'2 0.0989
5-25 6 0.9995 -3.25 x 10'2 0.0987
Average ± S.D. 6 0.9992 ± 
2,9 x 10‘2
-2.9 x 10"2± 0.017 0.098 ± 0.00
Table (vii) Precision and Accuracy for Troniethamine Analysis: Day One
Conc.Analyte 
(mg / L)
Average Peak 
Height (cm")
S.D. X + S.D. X - S.D. % R.S.D.
5 2.65 1.144 3.769 1.481 4.35
10 6.825 0.6993 7.524 6.125 10.24
15 10.40 0.3829 10.782 10.017 3.68
20 12.525 0.206 12.731 12.319 1.64
25 15.00 0.6633 15.663 14.336 4.42
Day Two
Cone. Analyte 
(mg / L)
Average Peak 
Height (cm'1)
S.D. X + S.D. X - S.D. % R.S.D.
5 2.20 0.3741 1.825 2.575 17.00
10 5.125 0.05 5.175 5.075 0.9756
15 6.70 0.959 5.741 7.659 13.31
20 9.175 0.7228 8.452 9.897 7.877
25 10.90 1.9949 8.905 12.895 18.25
Day Three
Conc.Analyte 
(mg / L)
Average Peak 
Height (cm'1)
S.D. X + S.D. X - S.D. % R.S.D.
5 0.36 0.0478 3.58 3.68 1.314
10 7.12 0.1699 6.96 7.30 2.381
15 10.53 0.0478 10.48 10.58 0.453
20 13.61 0.3009 13.31 13.91 2.210
25 16.00 0.0125 16.06 16.08 0.070
Day Four
Cone.x4nalyte 
(mg / L)
Average Peak 
Height (cm")
S.D. X + S.D. X - S.D. % R.S.D.
5 3.225 0.0645 3.289 3.160 2.00
10 6.163 0.1844 6.347 5.978 2.992
15 9.025 0.2060 9.231 8.819 2.282
20 11.52 0.8224 12.344 10.695 7.156
25 13.62 4.2224 17.842 9.397 30.99
Table (viii) Changing Electrolyte pH for OTC Analysis
pH Concentration OTC 
(mg / L)
OTC migration (min) EOF migration (min)
7.04 200 5.50 4.32
7.50 200 5.14 4.1
8.09 200 5.01 3.98
8.53 200 4.85 3.77
9.04 200 4.50 3.35
9.50 200 3.60 2.89
10.04 200 2.76 1.65
10.38
ooCN 2.16 1.12
Table (ix) Altering Voltage tor OTC Analysis
Voltage
(kV)
Migration Analyte 
(min)
Migration EOF (min) Current 
in  A)
15 7.20 5.98 31
16 6.70 5.60 jj
17 6.30 5.32 36
18 5.90 5.14 38
19 5.40 4.80 41
20 5.02 4.63 42
21 4.80 4.00 44
22 4.01 3.17 46
23 3.60 2.60 50
24 2.89 2.01 54
25 2.03 1.50 58
Table (x) Altering Ionic Strength for OTC Analysis
Concentration of 
Tris (mM)
Analyte 
Migration (min)
EOF Migration 
(man)
Current
(pA)
Temperature
(°C)
10 3.54 3.29 14 20.6
20 3.98 3.64 20 20.8
30 4.22 3.77 25 21.0
40 4.39 3.85 30 21.1
50 5.00 3.83 48 21.2
60 5.24 3.87 58 21.2
70 5.54 3.90 71 21.2
Table (xi) Linearity Studies for OTC Analysis
Concentration of 
OTC 
(mg / L)
Migration time 
(min)
Average Peak 
Area (x 1G6)
Average Peak 
Height (cm'1)
12.5 5.01 0.0615 0.725
25 5.13 0.0326 1.375
50 4.98 0.3210 2.940
100 5.00 0.5016 5.425
200 5.01 1.1631 11.260
Table (xii) Precision and Accuracy for OTC Analysis: Day One
Conc.Analyte 
(mg / L)
Average Peak 
Height (cm'1)
S.D. X + S.D. X - S.D. % R.S.D.
12.5 0.725 0.0134 0.7384 0.7116 1.848
25 1.375 0.0532 1.4282 1.3218 3.869
50 2.940 0.0567 2.9967 2.8833 1.928
100 5.425 0.0654 5.4909 5.3596 1.205
200 11.623 1.1640 12.787 10.459 10.01
Day I Vv'O
Conc.Analyte 
(mg / L)
Average Peak 
Height (cm-1)
S.D. X + S.D. X - S.D. % R.S.D.
12.5 0.780 0.02114 0.80114 0.7588 2.710
25 1.512 0.04221 1.5542 1.4697 2.790
50 3.060 0.03012 3.0901 3.0290 0.980
100 6.400 0.0324 6.4132 6.3861 0.206
200 10.480 0.9124 11.3924 9.567 8.706
Day Three
Conc.Axialyte
(mg/L)
Average Peak 
Height (cm"1)
S.D. X + S.D. X - S.D. % R.S.D.
12.5 0.700 0.0106 0.7106 0.6894 1.514
25 1.375 0.0523 1.4273 1.3227 3.803
50 3.375 0.0489 3.4239 3.3261 1.448
100 7.310 0.0700 7.3800 7.240 0.957
200 14.150 0.0980 14.248 14.052 0.6925
Day Four
Conc.Analytc 
(mg / L)
Average Peak 
Height (cm-1)
S.D. X + S.D. X - S.D. % R.S.D.
12.5 0.722 0.0653 0.7873 0.6567 9.044
25 1.454 0.0412 1.4952 1.4128 2.833
50 2.998 0.0191 3.0171 2.9789 0.637
100 6.056 0.0298 6.0858 6.0262 0.492
200 11.997 0.0954 12.092 11.901 0.795
Analyst, August 1998, Vol. 123 (1757-1760) 1757
Determination of tromethamine in an eye-care 
pharmaceutical by capillary electrophoresis
Fiona A. McArdle* and Catherine J. Meehan
Department of Applied Science, Institute of Technology, Sligo, Ireland
Tromethamine [tris(hydroxymethyl)aminomethane] is 
used as an emulsifying agent, alkaliser and buffering 
agent in pharmaceutical preparations such as eye-care 
solutions. A new method for the determination of this 
compound in an eye-care preparation was developed 
using capillary zone electrophoresis with indirect UV 
detection. The method displayed linearity between 2.5 and 
25 mg I-1 with a correlation coefficient of 0.9992. The 
limit of detection was 2.5 mg I-1 . Precision and accuracy 
were determined as relative standard deviation and % 
deviation, and were found to be 0.42% and 1.62%, 
respectively. Recovery studies of tromethamine in the 
pharmaceutical preparation gave a 102.98% recovery.
Keywords: Capillary electrophoresis; eye-care 
pharmaceutical; indirect UV detection; tromethamine
Capillary electrophoresis (CE) is gaining widespread ac­
ceptance as a standard analytical technique in pharmaceutical 
analysis. It has been employed in the determination of a variety 
of compounds including pharmaceuticals, 1 - 4  proteins,s - 7  poly­
mers,x amines9 and food constituents. 1 0 -1 2  The eye-care 
industry lias used CE to determine the constituents of contact 
lens cleaning fluids and ionic components in tears. 13 The main 
limitation of CE in pharmaceutical analysis is its lack of 
sensitivity and this is particularly true when determining trace 
chemicals in complex matrices. 14 However for the analysis of 
bulk pharmaceuticals or where low limits of detection are not 
required, this is not nesscessarily a problem.
In this study, CE was used to determine tromethamine 
|tris(hydroxymethyl)aminomethane]. Tromethamine is a weak 
amine base which is readily soluble in water. It is easily ionised 
and has a pK), of 7.8 at body temperature. 15 It is commonly used 
as a buffering agent, aikaliser and emulsifying agent in 
pharmaceutical and cosmetic products. This work was focused 
on determining tromethamine in it contact lens cleaning 
solution.
Tromethamine has been determined by high-performance 
liquid chromatography (HPLC) with fluorescence16 and UV17 
detection with retention times of 12 and 15 min, respectively. It 
has also been determined by ion chromatography (IC) with 
conductivity detection18 and by gas chromatography (GC) with 
flame ionisation detection19 with retention times of 5.4 and 3.6 
min, respectively. For fluorescence, UV and flame ionisation 
detection, derivatisation of tromethamine is required, which 
leads to lengthy sample preparation times.
Tromethamine in its ionised state possesses electrophoretic 
mobility and, although it cannot be detected by direct UV 
detection, indirect UV detection was used in this study. Indirect 
UV detection has been used previously for the detection of 
inorganic ions by CE.20
Dimethyldiphenylphosphonium hydroxide (DDP) was cho­
sen as the UV-absorbing species in this study as-it possesses the 
same charge as the analyte under the conditions used. It is a 
highly mobile ion and can act as both electrolyte, facilitating 
electroosmotic flow, and absorbing species, allowing indirect 
UV detection. It is obtained by passing dimethyldiphenylphos­
phonium iodide (DDPI) through ait anion-exchange cartridge. 
The UV detector displays a decrease in absorbance as the non­
absorbing analyte passes through the detection cell. The polarity 
of the output signal is reversed to allow positive peaks to be
observed.
This paper presents a validated method for the determination 
of tromethamine in a contact lens cleaning solution by capillary 
zone electrophoresis (CZE). The method uses indirect UV 
detection and requires minimal sample preparation.
Experimental
Reagents
DDPI and a-hydroxyisobutyric acid were purchased from 
Sigma-Aldrich (Dublin, Ireland), anion-exchange solid-phase 
extraction cartridges from Dionex UK, Camberely, Surrey, 
UK), tromethamine (ultra-pure grade. 99.9%) from Allergan 
Pharmaceuticals (Westport, Co. Mayo, Ireland) and analytical- 
reagent grade methanol from Lab Scan (Dublin, Ireland). All 
solutions were prepared with water purified in a Millipore Milli- 
Q water purification system. (ACJB Scientific, Dublin, Ire­
land).
Apparatus
Experiments were carried out using a CF.SI capillary electro­
phoresis system, (Dionex, UK) equipped with an on-capillary 
UV detector operated at 215 nni. Data were collected on a 
Dionex Model 4270 Integrator. Bare fused silica capillaries (50 
pm id X 375 pm od) were also purchased from Dionex. A 
Metrohm Model 713 pH meter (Foss Electric, Dublin, Ireland) 
was used for measuring pH.
Gravity injection was employed, with the sample vials raised 
to a height of 100 mm for 30 s. A voltage of 20 kV (detector side 
cathodic) was applied. The detector was used in the reversed 
polarity mode. The capillary was rinsed with the run buffer for 
120 s between injections. Optimum operating conditions were 
determined by investigating the effect of changes in the ionic 
strength of the buffer, temperature, pH and applied voltage.
Capillary preparation
Fused silica capillaries, 50 cm long, were prepared in ac­
cordance with the instrument manufacturer’s instructions.20 
The capillary was conditioned for use by flushing with 1 M 
NaOH for 45 min, rinsing with de-ionised water for 30 min 
followed by conditioning with buffer for 1 h to equilibrate the 
capillary sufficiently.
Buffer preparation
A DDPI solution was prepared by diluting the appropriate 
amount with de-ionised water to give a final concentration of 25 
X 10- 3 M. It was necessary to heat this solution to approx­
imately 80 °C to ensure complete dissolution of the DDPI. This 
solution, when cool, was passed through an anion exchange 
solid phase extraction cartridge, at a rate of 2
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Fig. 3 Calibration curve o f troniethaniinc concentration (2.5-25 mg I ') 
versus peak area; r3 = 0.9992. slope =  0.098 absorbance 1 mg-1 . 
Electrolyte, 5 x 10 1 m DDP buffer (pl-l û.5); UV detection at 215 nm. 
Electrophoretic conditions; capillary, 50 cm X 50 pm id; voltage. 20 kV 
(detector catbodic); gravity injection, 100 mm, 30 s.
2 r 2
(a) i
(b)
s LD
I w Ie0
L 8<0 «*—
Placebo spiked with tromethamine Placebo
Fig. 4 Electropherograms of placebo containing TrisChem (polyhexa- 
methylene biguanide), tyloxapol and disodium edetale. (a) with and (b) 
without tromethamine at 12 mg m l-1 . DDP buffer (pH 6.5) concentration. 
5 X 10~3 M; UV detection at 215 nm. Electrophoretic conditions: capillary, 
50 cm X 50 pm id; voltage, 20 kV (detector cathodic); gravity injection, 100 
mm, 30 s. Peaks 1 = tromethamine; 2 = solvent.
The limit of detection was determined and found to be 2.5 
mg l-1 , based on three times the standard deviation of the 
background noise.
The specificity of the method was investigated by injecting a 
placebo containing TrisChem (polyhexamethylenc biguanide), 
tyloxapol and disodium edetate diluted I : 1 0 0 0  v/v with de­
ionised water. No response appeared at the migration time of 
tromethamine when the placebo was injected alone (Fig. 4). A 
small peak was observed at 1.91 min in all electropherograms. 
Sodium residues may exist on the internal capilllary wall post­
conditioning and this peak was observed to increase upon 
addition of sodium to the standards. This suggests that the peak 
is due to the presence of sodium. This did not interfere with the 
tromethamine peak.
Reproducibility of the injection was determined by perform­
ing 10  successive injections of a 2 0  mg ml- 1  standard solution. 
The relative standard deviation (RSD) was found to be 2.0%.
The precision and accuracy of the method were determined 
by conducting intra- and inter-assay variability tests on a series 
of standards in the concentration range 2.5-25 mg m l_1 (Table 
1). The standards were diluted 1 : 1000 v/v as indicated in the 
Standards and samples section. Over the concentration range 
studied the average RSD was found to be 0.42% and the average 
deviation was found to be 1.62%. The average deviation is 
inflated owing to the relatively poor deviation obtained for the 
concentration of 5 mg ml-1. The remaining four concentrations 
give a deviation of 0.94%. As the concentration of the sample, 
1 2  mg ml-1, is within the range of these four standards, the 
result is acceptable.
Table 1 Precision and accuracy test results. Intra- and inter-assay variability 
tests with tromethamine (2 .5-25 m g l“ 1) versus peak area (n = 5) 
Electrolyte, 5 X 10~3 m DDP buffer (pH 6.5); UV detection at 215 nm. 
Electrophoretic conditions: capillary, 50 cm X 50 pm id; voltage, 20 kV 
(detector cathodic); gravity injection, 100 mm, 30 s
Correlation
coefficient Intercept Slope
0.9993 -2 .6 3  X 1 0 -2 0.0959
0.9992 -4 .0 4  X 1 0 -2 0.1013
0.9988 -2 .0 7  X 1 0 -2 0.0989
0.9995 -3 .2 5  X 1 0 -2 0.0987
; 0.9992 ± ( - 2 .9  X IO“ 2) ± 0.017 0.098 ±
2.9 X 10 3 0.002
Recovery studies over the concentration range 2.5-25 
mg ml- 1  were conducted by spiking (a) placebo Complete 
solutions and (b) de-ionised water with tromethamine. These 
solutions were then diluted 1 : 1 0 0 0  v/v prior to injection on to 
the CE capillary. A mean recovery of 102.98 + 2.59% was 
obtained. This relatively large variation may be due to the 
difference in the ionic strength of the sample solution and the 
distilled water standards. There was no significant difference in 
the migration times or peak shapes for the spiked placebo and 
the spiked distilled water standards.
The method developed represents a simple analytical proce­
dure for the determination of tromethamine in an eye-care 
pharmaceutical preparation. This method compares favourably 
with other reported methods for tromethamine determination. 
Previously reported methods using HPLC1 6 ' 7 or GCly involve 
lengthy sample and standard preparation, involving derivatisa- 
tion of tromethamine. The CE method developed here only 
requires dilution of the sample. Also, the previously reported 
chromatographic methods have run times of 12-15 min for 
HPLC, 1617 5.4 min for IC18 and 3.6 min for GC. 19 The 
proposed CE method has a shorter run time of 2,38 min, but it 
does require a capillary rinse time of 2  min between injections. 
The instrument set-up and conditioning limes are similar for 
both HPLC and CE. The total analysis time, including sample 
and standard preparation and run time, is significantly less with 
CE than with the previously reported chromatographic meth­
ods. Overall, CE uses smaller volumes of buffer and sample 
than HPLC, the capillaries are cheaper than HPLC columns and, 
coupled with the simple sample preparation required, the 
measurement of tromethamine concentrations using the method 
detailed in this paper would be more cost effective than using a 
chromatographic method.
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Determination of tromethamine in an eye-care 
pharmaceutical by capillary electrophoresis
Fiona A. McArdle’ and Catherine J. Meehan
Department of Applied Science, Institute of Technology, Sligo, Ireland
Tromethamine [tris(hydroxymethyl)aminomethane] is 
used as an emulsifying agent, alkaliser and buffering 
agent in pharmaceutical preparations such as eye-care 
solutions. A new method for the determination of this 
compound in an eye-care preparation was developed 
using capillary zone electrophoresis with indirect UV 
detection. The method displayed linearity between 2.5 and 
25 mg l-1 with a correlation coefficient of 0.9992. The 
limit of detection was 2.5 mg I-1 . Precision and accuracy 
were determined as relative standard deviation and % 
deviation, and were found to be 0.42% and 1.62%, 
respectively. Recovery studies of tromethamine in the 
pharmaceutical preparation gave a 102.98% recovery.
Keywords: Capillary electrophoresis; eye-care 
pharmaceutical; indirect UV detection; tromethamine
Capillary electrophoresis (CE) is gaining widespread ac­
ceptance as a standard analytical technique in pharmaceutical 
analysis. It has been employed in the determination of a variety 
of compounds including pharmaceuticals, 1 - 4  proteins,5 - 7  poly­
mers,8 amines9 and food constituents. 1 0 -12  The eye-care 
industry has used CE to determine the constituents of contact 
lens cleaning fluids and ionic components in tears. 13 The main 
limitation of CE in pharmaceutical analysis is its lack of 
sensitivity and this is particularly true when determining trace 
chemicals in complex matrices. 14 However for the analysis of 
bulk pharmaceuticals or where low limits of detection are not 
required, this is not nesscessarily a problem.
In this study, CE was used to determine tromethamine 
|iris(hydroxymethyl)aminomelhane]. Tromethamine is a weak 
amine base which is readily soluble in water, it is easily ionised 
and has a pKb of 7.8 at body temperature. 15 It is commonly used 
as a buffering agent, alkaliser and emulsifying agent in 
pharmaceutical and cosmetic products. This work was focused 
on determining tromethamine in a contact lens cleaning 
solution.
Tromethamine has been determined by high-performance 
liquid chromatography (HPLC) with fluorescence16 and UV17 
detection with retention times of 12 and 15 min, respectively. It 
has also been determined by ion chromatography (IC) with 
conductivity detection18 and by gas chromatography (GC) with 
flame ionisation detection19 with retention times of 5.4 and 3.6 
min, respectively. For fluorescence, UV and flame ionisation 
detection, derivatisation of tromethamine is required, which 
leads to lengthy sample preparation times.
Tromethamine in its ionised state possesses electrophoretic 
mobility and, although it cannot be detected by direct UV 
detection, indirect UV detection was used in this study. Indirect 
UV detection has been used previously for the detection of 
inorganic ions by CE.20
Dimethyldiphenylphosphonium hydroxide (DDP) was cho­
sen as the UV-absorbing species in this study as-it possesses the 
same charge as the analyte under the conditions used. It is a 
highly mobile ion and can acl as both electrolyte, facilitating 
electroosmotic flow, and absorbing species, allowing indirect 
UV detection. It is obtained by passing dimethyldiphenylphos-
phomum iodide (DDP1) through an anion-exclumge cartridge. 
The UV detector displays a decrease in absorbance as the non- 
absorbing analyte passes through the detection cell. The polarity 
of the output signal is reversed to allow positive peaks to be
observed.
This paper presents a validated method for the determination 
of tromethamine in a contact lens cleaning solution by capillary 
zone electrophoresis (CZE). The method uses indirect UV 
detection and requires minimal sample preparation.
Experimental
Reagents
DDPI and a-hydroxyisobutyric acid were purchased from 
Sigma-Aldrich (Dublin, Ireland), anion-exchange solid-phase 
extraction cartridges from Dionex UK, Camberely, Surrey, 
UK), tromethamine (ultra-pure grade, 99.9%) from Allergan 
Pharmaceuticals (Westport, Co. Mayo, Ireland) and analytical- 
reagent grade methanol from Lab Scan (Dublin, Ireland). All 
solutions were prepared with water purified in a Millipore Milli- 
Q water purification system. (AGB Scientific, Dublin, Ire­
land).
Apparatus
Experiments were carried out using a CES I capillary electro­
phoresis system, (Dionex, UK) equipped with an on-capillary 
UV detector operated at 215 nm. Data were collected on a 
Dionex Model 4270 Integrator, Bare fused silica capillaries (50 
pm id X 375 pm od) were also purchased from Dionex. A 
Metrohm Model 713 pH meter (Foss Electric, Dublin, Ireland) 
was used for measuring pH.
Gravity injection was employed, with the sample vials raised 
to a height of 100 mm for 30 s. A voltage of 20 kV (detector side 
cathodic) was applied. The detector was used in the reversed 
polarity mode. The capillary was rinsed with the run buffer for 
120 s between injections. Optimum operating conditions were 
determined by investigating the effect of changes in the ionic 
strength of the buffer, temperature, pH and applied voltage.
Capillary preparation
Fused silica capillaries, 50 cm long, were prepared in ac­
cordance with the instrument manufacturer’s instructions.20 
The capillary was conditioned for use by flushing with 1 m  
NaOH for 45 min, rinsing with de-ionised water for 30 min 
followed by conditioning with buffer for 1 h to equilibrate the 
capillary sufficiently.
Buffer preparation
A DDPI solution was prepared by diluting the appropriate 
amount with de-ionised water to give a final concentration of 25 
X  10 3 m. It was necessary to heat this solution to approx­
imately 80 °C to ensure complete dissolution of the DDPI. This 
solution, when cool, was passed through an anion exchange 
solid phase extraction cartridge, at a rate of 2
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ml min-1 . The first 2 ml of eluate were discarded. A 20 ml 
volume of the eluate was diluted to 1 0 0  ml and the ratio of eluate 
to a-hydroxyisobutyric acid was varied to optimise the 
separation and run time. All electrolyte solutions were vacuum 
filtered through a 0.45 pm nylon 6 ,6  filter before use.
Standards and samples
A 100 mg I“ 1 stock standard solution of tromethamine was used 
as the primary standard. This was prepared fresh daily. Working 
standard solutions in the range 5-25 mg l- 1  were prepared from 
the primary standard.
Samples of an eye-care solution, Complete, were supplied by 
Allergan Pharmaceuticals. This sample was stated to have a 
tromethamine concentration of 12 mg ml-1 . The sample 
preparation involved dilution of the sample 1 : 1 0 0 0  v/v with de­
ionised water. Samples of Complete containing all constituents 
except tromethamine (placebo) were also supplied and these 
were used in validation and recovery studies. All standard and 
samples were passed through a 0.45 pm nylon 6 ,6  filter to 
remove any particulate matter present before injection on to the 
capillary.
Results and discussion 
Optimisation o f CE conditions
As tromethamine does not contain an absorbing species, its 
determination was attained by using indirect UV detection. The 
absorbing species used was DDP. In spectrometric studies DDP 
was found have a molar absorptivity of 1.65 X 105 mol- 1  dm2 
and to obey the Beer-Lambert law up to a concentration of 1.4 
X  10 2 M at a wavelength of 215 nm. A linear regression of 
0.9984 was obtained for DDP concentration versus absorption. 
As DDP is a cation and contributes to the electroosmotic flow 
(EOF), varying its concentration affects the EOF in CZE. The 
DDP concentration was varied between 0.32 X  10" 3 and 5.0 X 
10" 3 M and it was found that increasing the concentration 
caused a decrease in the migration time of the tromethamine 
(Fig. 1). This is largely due to the increase in EOF at higher 
DDP concentrations. However, at high electrolyte concentra­
tions the current generated upon application of the voltage 
exceeded the manufacturer’s recommended limit and caused the 
instrument to cut out. For this reason, the concentration of DDP 
used in the electrolyte for CZE was 5 X  10~ 3 m.
Using a DDP concentration of 5 X 10- 3  m, the pH of the 
electrolyte was varied by altering the amount of a-hydrox- 
yisobutyric acid and this caused a change in the EOF and 
electrophoretic mobility of tromethamine (Fig. 2). The EOF was 
taken as the retention of the solvent in which the samples and 
standards were dissolved. This solvent did not contain UV
Fig. 1 Variation of migration time of tromethamine (12 mg 1~!) with DDP 
buffer (pH 6.5) concentration in the range 0.32 X ] 0 5 X 10"3 m. UV
detection at 215 nm. Electrophoretic conditions: capillary, 50 cm X 50 pm 
id; voltage, 20 kV (detector cathodic); gravity injection, 100 mm, 30 s.
absorbing species and therefore a peak was observed as it 
eluted. At pH < 3.0, the EOF was very slow, owing to the 
suppressed ionisation of the silanoate residues on the internal 
capillary wall, thus reducing the zeta potential. At pH > 7, 
tromethamine eluted with the EOF, indicating that at this pH 
tromethamine has no charge. In all subsequent work, pH 6.5 was 
used.
The applied voltage was varied in the range 15-25 kV. The 
migration time of tromethamine decreased with increasing 
applied voltage, as expected. It was decided to use an applied 
voltage of 20 kV in all subsequent work, because high applied 
voltages can result in Joule heating21 and the instrument 
employed did not have a thermostat facility.
Day-to-day temperature variations inside the capillary hous­
ing from 15 to 20 °C were noted, but this did not have a 
significant effect on the tromethamine peak shape or migration 
time. To ensure minimum temperature fluctuations, a cooling 
jacket was placed on the capillary at all times.
Validation
Using the DDP buffer, at a concentration of 5 X 10- 3  M and 
with a pH of 6.5, a linear signal was obtained from standard 
tromethamine solutions in the range 2.5-25 mg I- 1  and gave a 
regression coefficient of 0.9992 (Fig. 3). The sensitivity of the 
system was evaluated from the slope of the linear regression line 
and was found to be 0.098 absorbance 1 m g"1.
4 .6 5  5 .5 0  6 .07  7 .0 7  9.81
Electrolyte pH
Fig. 2 (a) Electrolyte pH versus (■ )  electrophoretic mobility of
tromethamine (20 mg l " 1) and ( ♦ )  mobility of solvent peak, (b) Electrolyte
pH versus ( ♦ )  migration lime of tromethamine (20 mg 1 " ')  and (■ ) 
migration time of solvent peak. UV detection at 215 nm. Electrophoretic 
conditions: capillary, 50 cm X 50 pm id; voltage, 20 kV (detector cathodic); 
gravity injection, 100 mm, 30 s.
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Fig. 3 Calibration curve o f tromethamine concentration (2.5-25 rag I-1 ) 
versus peak area; r2 = 0.9992, slope = 0.098 absorbance 1 m g- 1 . 
Electrolyte, 5 X IO-3  m  DDP buffer (pH 6.5); UV detection at 215 n m . 
Electrophoretic conditions: capillary, 50 cm X 50 pm id; voltage, 20 kV 
(detector cathodic); gravity injection, 100 inm, 30 s.
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Fig. 4 Electropherograms of placebo containing TrisChem (polyhexa- 
methylene biguanide), tyloxapol and disodium edetate, (a) with and (b) 
without tromethamine at 12 mg m l- 1 . DDP buffer (pH 6.5) concentration, 
5 X 10-3  m ; UV detection at 215 nm. Electrophoretic conditions: capillary, 
50 cm X 50 pm id; voltage, 20 kV (detector cathodic); gravity injection, 100 
mm, 30 s. Peaks 1 = tromethamine; 2 = solvent.
The limit of detection was determined and found to be 2.5 
mg l ' 1, based on three times the standard deviation of the 
background noise.
The specificity of the method was investigated by injecting a 
placebo containing TrisChem (poiyhexamcthylene biguanide), 
tyloxapol and disodium edetate diluted 1 : 1 0 0 0  v/v with de­
ionised water. No response appeared at the migration time of 
tromethamine when the placebo was injected alone (Fig. 4). A 
small peak was observed at 1.91 min in all electropherograms. 
Sodium residues may exist on the internal capilllary wall post- 
conditioning and this peak was observed to increase upon 
addition of sodium to the standards. This suggests that the peak 
is due to the presence of sodium. This did not interfere with the 
tromethamine peak.
Reproducibility of the injection was determined by perform­
ing 10  successive injections of a 2 0  mg ml- 1  standard solution. 
The relative standard deviation (RSD) was found to be 2.0%.
The precision and accuracy of the method were determined 
by conducting intra- and inter-assay variability tests on a series 
of standards in the concentration range 2.5-25 mg ml- 1  (Table 
1). The standards were diluted 1: 1000 v/v as indicated in the 
Standards and samples section. Over the concentration range 
studied the average RSD was found to be 0.42% and the average 
deviation was found to be 1.62%. The average deviation is 
inflated owing to the relatively poor deviation obtained for the 
concentration of 5 mg ml“ 1. The remaining four concentrations 
give a deviation of 0.94%. As the concentration of the sample, 
1 2  mg ml-1, is within the range of these four standards, the 
result is acceptable.
Table 1 Precision and accuracy test results. Intra- and inter-assay variability 
tests with tromethamine (2.5-25 mg l-1 ) versus peak area (n = 5) 
Electrolyte, 5 X 10-3 M DDP buffer (pH 6.5); UV detection at 215 nm. 
Electrophoretic conditions: capillary, 50 cm X 50 pm  id; voltage, 20 kV 
(detector cathodic); gravity injection, 100 mm, 30 s
Correlation
coefficient Intercept Slope
0.9993 - 2 .6 3  X K L 2 0.0959
0.9992 -4 .0 4  X 10“ 2 0.1013
0.9988 - 2 .0 7  X 10“ 2 0.0989
0.9995 - 3 .2 5  X 1CU2 0.0987
Average ± s 0.9992 + ( - 2 .9  X 10~2) + 0.017 0.098 ±
2.9 X IO“ 2 0.002
Recovery studies over the concentration range 2.5-25 
mg ml“ 1 were conducted by spiking (a) placebo Complete 
solutions and (b) de-ionised water with tromethamine. These 
solutions were then diluted 1 : 1 0 0 0  v/v prior to injection on to 
the CE capillary. A mean recovery of 102.98 ± 2.59% was 
obtained. This relatively large variation may be due to the 
difference in the ionic strength of the sample solution and the 
distilled water standards. There was no significant difference in 
the migration times or peak shapes for the spiked placebo and 
the spiked distilled water standards.
The method developed represents a simple analytical proce­
dure for the determination of tromethamine in an eye-care 
pharmaceutical preparation. This method compares favourably 
with other reported methods for tromethamine determination. 
Previously reported methods using I IPLCl6<17 or GC|,J involve 
lengthy sample and standard preparation, involving derival isa- 
lion of tromethamine. The CE method developed here only 
requires dilution of the sample. Also, the previously reported 
chromatographic methods have run times of 12-15 min for 
HPLC^.iv 5 .4  min for IC18 and 3.6 min for GC49 The 
proposed CE method has a shorter run time of 2.38 min, but it 
does require a capillary rinse time of 2  min between injections. 
The instrument set-up and conditioning tunes are similar for 
both HPLC and CE. The total analysis time, including sample 
and standard preparation and run time, is significantly less with 
CE than with the previously reported chromatographic meth­
ods. Overall, CE uses smaller volumes of buffer and sample 
than HPLC, the capillaries are cheaper than HPLC columns and, 
coupled with the simple sample preparation required, the 
measurement of tromethamine concentrations using the method 
detailed in this paper would be more cost effective than using a 
chromatographic method.
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